RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: myeloid leukemia
Accession: DOID:8692
browse the term
Definition: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
Synonyms: exact_synonym: Granulocytic Leukemia; Myelocytic Leukemia; Myelocytic Leukemias; Myelogenous Leukemia; Myelogenous Leukemias; Myeloid Leukemias; granulocytic leukemias; leukaemia myelogenous; myeloid granulocytic leukaemia; myeloid granulocytic leukemia; myeloid leukaemia; non-lymphocytic leukemia
narrow_synonym: chronic myeloid leukemia
primary_id: MESH:D007951
alt_id: OMIA:001573
xref: GARD:8226 ; ICD10CM:C92 ; ICD9CM:205 ; NCI:C21889 ; NCI:C3172
For additional species annotation, visit the
Alliance of Genome Resources .
G
Ago2
argonaute RISC catalytic component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21535412
NCBI chr 7:114,339,607...114,377,277
Ensembl chr 7:114,339,434...114,380,613
G
Atg2b
autophagy related 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26280900
NCBI chr 6:129,449,451...129,519,599
Ensembl chr 6:129,449,449...129,509,720
G
Camlg
calcium modulating ligand
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:12031912
RGD:2316229
NCBI chr17:9,523,792...9,534,683
Ensembl chr17:9,523,795...9,534,653
G
Cbx7
chromobox 7
treatment
ISO
RGD
PMID:26343356
RGD:11352715
NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
G
Csf3
colony stimulating factor 3
disease_progression
ISO
RGD
PMID:7510191
RGD:11039040
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
G
Dhfr
dihydrofolate reductase
ISO
RGD
PMID:12649191
RGD:11039541
NCBI chr 2:21,931,887...21,958,927
Ensembl chr 2:21,931,493...21,962,453
G
Erg
ETS transcription factor ERG
ISO
RGD
PMID:23719302
RGD:10450751
NCBI chr11:35,645,317...35,749,637
Ensembl chr11:35,646,116...35,749,594
G
Esr2
estrogen receptor 2
ISO
RGD
PMID:12740446
RGD:734951
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:19506298
RGD:11352666
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
RGD
PMID:17936561
RGD:11049465
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Gata1
GATA binding protein 1
ISO
RGD
PMID:23719302
RGD:10450751
NCBI chr X:15,273,937...15,281,759
Ensembl chr X:15,378,789...15,382,066
G
Gata2
GATA binding protein 2
disease_progression
ISO
DNA:missense mutation:cds:p.L359V
RGD
PMID:19304323
RGD:11049517
NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
G
Gfi1
growth factor independent 1 transcriptional repressor
ISO
RGD
PMID:21732494
RGD:11040451
NCBI chr14:3,058,035...3,073,332
Ensembl chr14:3,058,993...3,068,371
G
Gskip
GSK3B interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26280900
NCBI chr 6:129,512,950...129,536,320
Ensembl chr 6:129,519,709...129,536,221
G
Gstm1
glutathione S-transferase mu 1
disease_progression
ISO
RGD
PMID:11906705 , PMID:16313269
RGD:10755328 , RGD:10755403
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:SNP:cds:p.I105V (rs1695) (human)
RGD
PMID:20843134
RGD:10755535
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
Gstt1
glutathione S-transferase theta 1
susceptibility no_association disease_progression
ISO
RGD
PMID:21254556 , PMID:16313269 , PMID:18760837
RGD:10755324 , RGD:10755403 , RGD:10755327
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
G
Hdac2
histone deacetylase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21535412
NCBI chr20:43,084,870...43,108,198
Ensembl chr20:43,084,870...43,108,198
G
Ifng
interferon gamma
treatment
ISO
RGD
PMID:20959405
RGD:10755686
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
protein:decreased expression:blood:
RGD
PMID:23716272
RGD:12743616
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
G
Kmt2a
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8282816 PMID:17463288
NCBI chr 8:49,110,407...49,185,872
Ensembl chr 8:49,114,990...49,158,971
G
Kmt2e
lysine methyltransferase 2E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18854576
NCBI chr 4:8,187,751...8,255,578
Ensembl chr 4:8,187,751...8,255,514
G
Mecom
MDS1 and EVI1 complex locus
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23770046
NCBI chr 2:117,396,084...117,993,604
Ensembl chr 2:117,396,007...117,454,769
G
Mn1
MN1 proto-oncogene, transcriptional regulator
ISO
acute myeloid leukemia, DNA:translocation
RGD
PMID:7731705
RGD:1600424
NCBI chr12:51,214,192...51,250,230
Ensembl chr12:51,214,192...51,250,230
G
Mpl
MPL proto-oncogene, thrombopoietin receptor
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:10621836
RGD:10449009
NCBI chr 5:137,268,412...137,282,032
Ensembl chr 5:137,269,480...137,281,298
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11882782
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nsd3
nuclear receptor binding SET domain protein 3
ISO
RGD
PMID:11986249
RGD:1599847
NCBI chr16:71,126,276...71,237,118
Ensembl chr16:71,130,668...71,237,118
G
Pdgfra
platelet derived growth factor receptor alpha
ISO
RGD
PMID:24486648
RGD:11075087
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
mRNA:increased expression:blood (human)
RGD
PMID:23772643
RGD:11541098
NCBI chr10:94,850,971...94,913,202
G
Prame
PRAME nuclear receptor transcriptional regulator
severity
ISO
human cell line in a mouse model
RGD
PMID:16103086
RGD:11535036
NCBI chr X:106,082,984...106,091,256
Ensembl chr X:106,083,203...106,085,878
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16932348
NCBI chr19:26,084,816...26,090,095
Ensembl chr19:26,084,903...26,090,094
G
Rad21
RAD21 cohesin complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23955599
NCBI chr 7:91,511,755...91,538,673
Ensembl chr 7:91,511,756...91,538,673
G
Setbp1
SET binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23832012
NCBI chr18:75,090,733...75,432,446
Ensembl chr18:75,095,632...75,207,306
G
Smarcd2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28369036
NCBI chr10:94,451,866...94,460,732
Ensembl chr10:94,451,866...94,460,732
G
Smc1a
structural maintenance of chromosomes 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23955599
NCBI chr X:21,710,976...21,755,708
Ensembl chr X:21,711,019...21,755,525
G
Smc3
structural maintenance of chromosomes 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23955599
NCBI chr 1:274,310,120...274,352,856
Ensembl chr 1:274,309,758...274,352,854
G
Snca
synuclein alpha
ISO
RGD
PMID:21264917
RGD:6478703
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
G
Spi1
Spi-1 proto-oncogene
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17361223
NCBI chr 3:79,918,127...79,937,708
Ensembl chr 3:79,918,969...79,938,301
G
Srsf1
serine and arginine rich splicing factor 1
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23228155
RGD:11038774
NCBI chr10:75,334,200...75,341,197
Ensembl chr10:75,335,146...75,341,197
G
Stag2
stromal antigen 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23955599
NCBI chr X:128,493,603...128,624,418
Ensembl chr X:128,493,614...128,624,418
G
Top2b
DNA topoisomerase II beta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16932348
NCBI chr15:10,262,972...10,319,741
Ensembl chr15:10,262,651...10,320,233
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
treatment
ISO
DNA:polymorphism: :
RGD
PMID:23609856
RGD:10768829
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21535412
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chr 6:26,657,507...26,680,459
Ensembl chr 6:26,657,780...26,680,284
G
Dhodh
dihydroorotate dehydrogenase (quinone)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chr19:42,066,103...42,087,906
Ensembl chr19:42,066,351...42,082,012
G
Umps
uridine monophosphate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chr11:70,034,181...70,044,590
Ensembl chr11:70,034,139...70,044,628
G
Ddx41
DEAD-box helicase 41
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr17:9,631,925...9,637,317
Ensembl chr17:9,631,925...9,637,316
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
ClinVar Annotator: match by term: Acute erythroleukemia
ClinVar
PMID:27416908
NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Gfi1b
growth factor independent 1B transcriptional repressor
ISO
mRNA:increased expression:bone marrow cell:
RGD
PMID:17156408
RGD:11040507
NCBI chr 3:7,190,721...7,203,444
Ensembl chr 3:7,190,722...7,203,420
G
Hoxb9
homeo box B9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr10:84,119,772...84,124,963
Ensembl chr10:84,119,884...84,123,390
G
Kmt2a
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr 8:49,110,407...49,185,872
Ensembl chr 8:49,114,990...49,158,971
G
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr10:18,080,949...18,091,062
Ensembl chr10:18,080,950...18,090,950
G
Nup98
nucleoporin 98 and 96 precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr 1:167,213,866...167,308,851
Ensembl chr 1:167,213,866...167,308,851
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30926971
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
RGD
PMID:21640380
RGD:11081147
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
G
Apc
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
G
Birc5
baculoviral IAP repeat-containing 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16166298
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Coro7
coronin 7
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
NCBI chr10:11,090,200...11,144,289
Ensembl chr10:11,090,314...11,143,881 Ensembl chr10:11,090,314...11,143,881
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
associated with Down Syndrome;DNA:mutations:multiple (human)
RGD
PMID:24056718
RGD:10450890
NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
G
Gata1
GATA binding protein 1
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
PMID:15070711
NCBI chr X:15,273,937...15,281,759
Ensembl chr X:15,378,789...15,382,066
G
Gfi1b
growth factor independent 1B transcriptional repressor
ISO
mRNA:increased expression:bone marrow cell:
RGD
PMID:17156408
RGD:11040507
NCBI chr 3:7,190,721...7,203,444
Ensembl chr 3:7,190,722...7,203,420
G
Jak3
Janus kinase 3
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
PMID:10982185 PMID:16843266 PMID:18270328 PMID:18397343 PMID:20132407 PMID:20372971 PMID:20385788 PMID:20400977 PMID:21599579 PMID:21821710 PMID:22271575 PMID:24728327 PMID:25157968 PMID:28492532 , PMID:16843266
RGD:11531113
NCBI chr16:20,107,471...20,120,678
Ensembl chr16:20,109,200...20,120,668
G
Mdga1
MAM domain containing glycosylphosphatidylinositol anchor 1
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
NCBI chr20:8,515,142...8,574,632
Ensembl chr20:8,515,142...8,574,082
G
Mrtfa
myocardin related transcription factor A
ISO
RGD
PMID:11431691
RGD:1599948
NCBI chr 7:122,233,196...122,403,661
Ensembl chr 7:122,234,012...122,403,667
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Pcf11
PCF11 cleavage and polyadenylation factor subunit
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
NCBI chr 1:157,463,014...157,494,134
Ensembl chr 1:157,468,626...157,494,008
G
Prame
PRAME nuclear receptor transcriptional regulator
ISO
associated with Down Syndrome;mRNA:increased expression:mononuclear cell (human)
RGD
PMID:15180862
RGD:11535064
NCBI chr X:106,082,984...106,091,256
Ensembl chr X:106,083,203...106,085,878
G
Pten
phosphatase and tensin homolog
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
PMID:10848731 PMID:17941496 PMID:20600018 PMID:21194675 PMID:21343951 PMID:21659347 PMID:22281088 PMID:22520842 PMID:23335809 PMID:23475934 PMID:23886400 PMID:24778394 PMID:26376867 PMID:28492532 PMID:29663862
NCBI chr 1:251,421,814...251,487,634
Ensembl chr 1:251,421,596...251,487,832
G
Rasal3
RAS protein activator like 3
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
NCBI chr 7:14,403,592...14,419,570
Ensembl chr 7:14,403,592...14,418,950
G
Runx1
RUNX family transcription factor 1
onset
ISO
RGD
PMID:15856017
RGD:11251701
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
G
Slc9a2
solute carrier family 9 member A2
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
NCBI chr 9:47,386,581...47,491,813
Ensembl chr 9:47,386,626...47,491,907
G
Sncb
synuclein, beta
ISO
RGD
PMID:21264917
RGD:6478703
NCBI chr17:10,384,472...10,392,776
Ensembl chr17:10,384,511...10,392,843
G
Tp53
tumor protein p53
ISO
ClinVar Annotator: match by term: Acute megakaryoblastic leukemia
ClinVar
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21399634
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
G
Kmt2a
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8282816
NCBI chr 8:49,110,407...49,185,872
Ensembl chr 8:49,114,990...49,158,971
G
Mllt10
MLLT10, histone lysine methyltransferase DOT1L cofactor
ISO
RGD
PMID:7662954
RGD:1598771
NCBI chr17:84,847,660...84,981,134
Ensembl chr17:84,881,414...84,979,543
G
Nf1
neurofibromin 1
ISO
ClinVar Annotator: match by term: Acute monocytic leukemia
ClinVar
PMID:23407919 PMID:25741868 PMID:28492532
NCBI chr10:66,732,460...66,928,706
Ensembl chr10:66,690,133...66,928,903
G
Stk11
serine/threonine kinase 11
ISO
ClinVar Annotator: match by term: Acute monocytic leukemia
ClinVar
PMID:25117502 PMID:25741868 PMID:25980754 PMID:26467025 PMID:28492532
NCBI chr 7:12,440,751...12,457,513
Ensembl chr 7:12,440,751...12,457,513
G
Abcc3
ATP binding cassette subfamily C member 3
disease_progression
ISO
RGD
PMID:26512967
RGD:11081145
NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
G
Abcg2
ATP binding cassette subfamily G member 2
disease_progression treatment
ISO
RGD
PMID:26512967 , PMID:12145683
RGD:11081145 , RGD:11099971
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
DNA:translocation: :
RGD
PMID:12161353
RGD:10450603
NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
G
Acsl6
acyl-CoA synthetase long-chain family member 6
ISO
DNA:translocation: :t(5;12)(q31;p13) (human)
RGD
PMID:10502316
RGD:1599805
NCBI chr10:39,654,771...39,717,592
Ensembl chr10:39,655,455...39,719,312
G
Adcy7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr19:19,702,307...19,762,973
Ensembl chr19:19,704,859...19,727,081
G
Agrn
agrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 5:173,589,910...173,622,813
Ensembl chr 5:173,589,819...173,622,645
G
Alk
ALK receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 6:22,696,415...23,203,791
Ensembl chr 6:22,696,397...23,203,775
G
Anapc2
anaphase promoting complex subunit 2
ISO
mRNA:increased expression:blood (human)
RGD
PMID:26046517
RGD:11067888
NCBI chr 3:2,490,496...2,502,247
Ensembl chr 3:2,490,518...2,502,248
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
G
Anxa5
annexin A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 2:123,162,477...123,194,730
Ensembl chr 2:123,162,461...123,193,130
G
Anxa6
annexin A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr10:40,320,581...40,375,605
Ensembl chr10:40,320,581...40,375,605
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16968895
NCBI chr 8:77,559,621...77,599,781
Ensembl chr 8:77,559,624...77,599,781
G
Arid4a
AT-rich interaction domain 4A
ISS
OMIM:601626
MouseDO
NCBI chr 6:93,461,713...93,532,901
Ensembl chr 6:93,461,713...93,532,901
G
Asmtl
acetylserotonin O-methyltransferase-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr12:18,532,090...18,534,761
Ensembl chr12:18,531,990...18,534,836
G
Asxl1
ASXL transcriptional regulator 1
disease_progression
ISO ISS
DNA:mutations:exon: OMIM:601626
MouseDO
PMID:20693432
RGD:11038706
NCBI chr 3:148,832,231...148,902,356
Ensembl chr 3:148,837,814...148,900,452
G
Asxl2
ASXL transcriptional regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27798625
NCBI chr 6:27,835,346...27,919,285
Ensembl chr 6:27,887,797...27,915,563
G
Atg2b
autophagy related 2B
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid
ClinVar
NCBI chr 6:129,449,451...129,519,599
Ensembl chr 6:129,449,449...129,509,720
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr13:82,737,161...82,757,681
Ensembl chr13:82,737,159...82,758,004
G
Baalc
BAALC binder of MAP3K1 and KLF4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19822134
NCBI chr 7:77,761,056...77,836,534
Ensembl chr 7:77,763,512...77,837,453
G
Bach2
BTB domain and CNC homolog 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21441929
NCBI chr 5:47,458,891...47,807,176
Ensembl chr 5:47,546,014...47,807,166
G
Bcl2
BCL2, apoptosis regulator
susceptibility severity
ISO
DNA:snp:promoter:g.-938C>A (human) CTD Direct Evidence: marker/mechanism DNA:snp:exon:c.+21A>G (rs1801018) (human) ratio with Flt3, Kit;mRNA:decreased expression:mononuclear cell (human)
CTD
PMID:23906301 , PMID:25957891 , PMID:19520430 , PMID:25216797
RGD:11526107 , RGD:11526111 , RGD:11526109
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l1
Bcl2-like 1
severity
ISO
mRNA:increased expression:peripheral blood, bone marrow, blast cell (human)
RGD
PMID:11410409
RGD:11353851
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Bdkrb1
bradykinin receptor B1
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid
ClinVar
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
G
Bdkrb2
bradykinin receptor B2
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid
ClinVar
NCBI chr 6:129,399,468...129,429,676
Ensembl chr 6:129,399,468...129,429,676
G
Bmi1
BMI1 proto-oncogene, polycomb ring finger
ISO
RGD
PMID:16105758
RGD:1580059
NCBI chr17:85,360,439...85,370,283
Ensembl chr17:85,364,483...85,368,208
G
Brca2
BRCA2, DNA repair associated
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:15766593 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29021639
NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
G
Brd4
bromodomain containing 4
ISO
RGD
PMID:21814200
RGD:9586350
NCBI chr 7:14,222,101...14,303,055
Ensembl chr 7:14,222,101...14,303,055
G
Brd7
bromodomain containing 7
susceptibility
ISO
mRNA:increased expression:bone marrow: DNA:haplotype:cds:737A>G,495C>T(human)
RGD
PMID:18772500 , PMID:18772500
RGD:9586443 , RGD:9586443
NCBI chr19:19,672,780...19,701,484
Ensembl chr19:19,672,856...19,701,484
G
Btg1
BTG anti-proliferation factor 1
disease_progression
ISO
RGD
PMID:15449376
RGD:1549463
NCBI chr 7:37,812,831...37,815,088
Ensembl chr 7:37,812,831...37,815,088
G
Calr
calreticulin
ISO
mRNA:increased expression:peripheral blood (human)
RGD
PMID:26640226
RGD:11076986
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
G
Capg
capping actin protein, gelsolin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
G
Capn2
calpain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr13:100,878,649...100,928,811
Ensembl chr13:100,878,650...100,928,811
G
Casp7
caspase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
G
Cbfb
core-binding factor subunit beta
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:18206229 PMID:25741868 PMID:27798625
NCBI chr19:37,127,508...37,171,075
Ensembl chr19:37,127,508...37,171,069
G
Cbl
Cbl proto-oncogene
disease_progression
ISO
associated with Myelodysplastic Syndromes;DNA:mutations:exons:
RGD
PMID:22131879
RGD:11038796
NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
protein:increased expression:plasma (human)
RGD
PMID:25382729 , PMID:17822317
RGD:11528532 , RGD:11528537
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccna1
cyclin A1
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10068680
RGD:2316304
NCBI chr 2:144,456,689...144,503,570
Ensembl chr 2:144,458,153...144,467,912
G
Ccnd1
cyclin D1
treatment
ISO
mRNA:increased expression:bone marrow (human) human tumor in a mouse model
RGD
PMID:22391157 , PMID:21928377
RGD:11352824 , RGD:11353789
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
G
Ccnd2
cyclin D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27798625
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
G
Cd33
CD33 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12921496
NCBI chr 1:98,388,811...98,403,539
Ensembl chr 1:98,398,660...98,402,968
G
Cd44
CD44 molecule (Indian blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23098472
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
G
Cd86
CD86 molecule
severity
ISO
protein:increased expression:mononuclear cell of bone marrow (human)
RGD
PMID:19197726 , PMID:16115907
RGD:4892295 , RGD:11354960
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
G
Cd9
CD9 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 4:157,977,163...158,010,091
Ensembl chr 4:157,977,162...158,010,166
G
Cdh1
cadherin 1
disease_progression
ISO
DNA:hypermethylation:promoter:
RGD
PMID:15863205
RGD:11252161
NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
G
Cdk6
cyclin-dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr 4:27,781,728...27,969,653
Ensembl chr 4:27,785,647...27,966,398
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISO
DNA:deletion: :
RGD
PMID:9171997
RGD:10450601
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
disease_progression
ISO
DNA:deletion: : mRNA,protein:altered expression:bone marrow:
RGD
PMID:11064355 , PMID:11697625
RGD:11251749 , RGD:11252080
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
ISO
mRNA,protein:altered expression:bone marrow:
RGD
PMID:11697625
RGD:11252080
G
Cdkn2a_v2
cyclin-dependent kinase inhibitor 2A, variant 2
ISO
mRNA,protein:altered expression:bone marrow:
RGD
PMID:11697625
RGD:11252080
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
susceptibility treatment disease_progression
ISO
DNA:hypermethylation: : mRNA:decreased expression:granulocyte,monocyte: DNA:hypermethylation:promoter: DNA:deletion: :
RGD
PMID:25616284 , PMID:9001419 , PMID:14681685 , PMID:27168825 , PMID:15863205 , PMID:11064355
RGD:11251739 , RGD:11252196 , RGD:11252167 , RGD:11252164 , RGD:11252161 , RGD:11251749
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Cebpa
CCAAT/enhancer binding protein alpha
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar Annotator: match by term: Acute myelogenous leukemia CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: AML - Acute myeloid leukemia ClinVar Annotator: match by OMIM:601626
OMIM ClinVar CTD
PMID:11242107 PMID:12661007 PMID:12692518 PMID:14726504 PMID:15575056 PMID:18768433 PMID:18987666 PMID:19731081 PMID:19822134 PMID:23926458 PMID:24220272 PMID:24728327 PMID:25741868 PMID:26162409 PMID:26721895 PMID:27005833 PMID:28250006 PMID:28492532 PMID:29296967 PMID:30420649
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
G
Cebpd
CCAAT/enhancer binding protein delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234736
NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
G
Cfhr1
complement factor H-related 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:26317246
RGD:11341662
NCBI chr13:56,862,666...56,877,650
Ensembl chr13:56,836,994...56,877,650
G
Cflar
CASP8 and FADD-like apoptosis regulator
disease_progression
ISO
RGD
PMID:23167276
RGD:11341679
NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251
G
Chi3l1
chitinase 3 like 1
severity
ISO
protein:increased secretion:serum (human)
RGD
PMID:16361549
RGD:4892644
NCBI chr13:51,022,844...51,030,797
Ensembl chr13:51,022,681...51,030,802
G
Chic2
cysteine-rich hydrophobic domain 2
ISO
OMIM
NCBI chr14:35,683,657...35,718,005
Ensembl chr14:35,683,442...35,717,922
G
Chmp5
charged multivesicular body protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17708794
NCBI chr 5:57,267,312...57,284,455
Ensembl chr 5:57,267,312...57,284,448
G
Cnr2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15039279
NCBI chr 5:154,242,010...154,268,126
Ensembl chr 5:154,260,062...154,268,126
G
Crebbp
CREB binding protein
ISO ISS
DNA:translocations:intron:IVS2 (human) OMIM:601626
MouseDO
PMID:12461753
RGD:734819
NCBI chr10:11,590,994...11,721,039
Ensembl chr10:11,595,044...11,721,039
G
Csf1r
colony stimulating factor 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1390197
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
G
Csf2
colony stimulating factor 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21441929 , PMID:1826536
RGD:10449528
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
G
Csf3
colony stimulating factor 3
treatment
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7528855 , PMID:10673519
RGD:11039033
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
G
Csf3r
colony stimulating factor 3 receptor
disease_progression susceptibility
ISO
ClinVar Annotator: match by term: Acute myelocytic leukemia associated with Severe Congenital Neutropenia;DNA:nonsense mutation:cds:
ClinVar
PMID:23604229 PMID:23634996 PMID:23656643 PMID:24081659 PMID:24403076 PMID:24614839 PMID:24854193 PMID:25491280 PMID:25741868 PMID:25932451 PMID:26875968 PMID:27148573 PMID:27581359 PMID:28209919 PMID:28219221 PMID:28492532 PMID:28762112 PMID:30967555 , PMID:24746896 , PMID:9001427 , PMID:21911095
RGD:10450468 , RGD:10450487 , RGD:10450470
NCBI chr 5:144,031,353...144,051,966
Ensembl chr 5:144,031,402...144,051,600
G
Cst3
cystatin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 3:143,219,671...143,223,544
Ensembl chr 3:143,219,686...143,223,615
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
DNA:SNP:3'UTR:rs3087243(human)
RGD
PMID:19092854
RGD:11344911
NCBI chr 9:67,699,397...67,706,068
Ensembl chr 9:67,699,379...67,706,065
G
Ctnna1
catenin alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr18:27,923,229...28,055,972
Ensembl chr18:27,923,572...28,055,960
G
Ctsh
cathepsin H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 8:97,439,155...97,458,293
Ensembl chr 8:97,439,161...97,458,287
G
Ctsz
cathepsin Z
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 3:172,527,107...172,537,877
Ensembl chr 3:172,527,107...172,537,877
G
Cxcr4
C-X-C motif chemokine receptor 4
treatment disease_progression
ISO
RGD
PMID:26031918 , PMID:24035716
RGD:11352265 , RGD:11352273
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
disease_progression no_association
ISO
DNA:SNP: :6235T>C (human) DNA:polymorphism: :6235T>C (human) DNA:SNP: :4889A>G (human)
RGD
PMID:19456854 , PMID:15996939 , PMID:19456854
RGD:10769358 , RGD:11352736 , RGD:10769358
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
susceptibility
ISO
DNA:polymorphism:G15631T
RGD
PMID:19144407
RGD:6480472
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
susceptibility treatment
ISO
DNA:polymorphisms: : DNA:SNP: :(rs16947)(human)
RGD
PMID:11037802 , PMID:21518482
RGD:11352820 , RGD:11352828
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
G
Dapk1
death associated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19874806
NCBI chr17:4,297,038...4,454,941
Ensembl chr17:4,297,224...4,454,778
G
Ddx41
DEAD-box helicase 41
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:25741868 PMID:25920683 PMID:26712909
NCBI chr17:9,631,925...9,637,317
Ensembl chr17:9,631,925...9,637,316
G
Dhx15
DEAH-box helicase 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27798625 PMID:29163777
NCBI chr14:61,136,740...61,174,880
Ensembl chr14:61,136,746...61,174,880
G
Dlec1
DLEC1 cilia and flagella associated protein
treatment
ISO
DNA:hypermethylation:promoter:
RGD
PMID:27168825
RGD:11252164
NCBI chr 8:127,788,919...127,835,986
Ensembl chr 8:127,789,048...127,834,637
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA:increased expression:CD34+ bone marrow cells
RGD
PMID:11222358
RGD:9588667
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
G
Dnmt3a
DNA methyltransferase 3 alpha
disease_progression susceptibility treatment
ISO
mRNA:increased expression:CD34+ bone marrow cells ClinVar Annotator: match by term: Acute myeloid leukemia DNA:missense mutation:exon:p.R882 (human) associated with Myelodysplastic Syndromes; DNA:mutations:cds: DNA:hypomethylation: : DNA:mutation::
ClinVar OMIM
PMID:21067377 PMID:21518476 PMID:22160010 PMID:22722925 PMID:22744846 PMID:22898539 PMID:22898540 PMID:22898541 PMID:24606448 PMID:24622842 PMID:24656771 PMID:25741868 PMID:26619011 PMID:26876596 PMID:27991732 PMID:28432085 PMID:28492532 PMID:28941052 PMID:32581362 , PMID:11222358 , PMID:24512939 , PMID:21415852 , PMID:26242829 , PMID:25609058 , PMID:22291079
RGD:9588667 , RGD:11041123 , RGD:11041122 , RGD:11041121 , RGD:11041120 , RGD:9589067
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
G
Dnmt3b
DNA methyltransferase 3 beta
susceptibility disease_progression
ISO
mRNA:increased expression:CD34+ bone marrow cells DNA:SNP:promoter: C>T46359(human) DNA:SNPs,haplotype: :rs1569686,rs2424908, rs6087990, rs6119954(human)
RGD
PMID:11222358 , PMID:16194411 , PMID:24069326 , PMID:23251566
RGD:9588667 , RGD:9589108 , RGD:9589103 , RGD:9589071
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
Ehd3
EH-domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 6:25,076,012...25,102,457
Ensembl chr 6:25,074,955...25,100,977
G
Ehmt2
euchromatic histone lysine methyltransferase 2
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24532712 , PMID:24532712
RGD:9589168
NCBI chr20:4,576,033...4,592,980
Ensembl chr20:4,576,057...4,592,980
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19458359
NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248
G
Enah
ENAH, actin regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26237430
NCBI chr13:100,297,421...100,415,335
Ensembl chr13:100,300,054...100,414,226
G
Eno2
enolase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 4:157,285,192...157,294,090
Ensembl chr 4:157,285,179...157,294,047
G
Ephx1
epoxide hydrolase 1
no_association
ISO
DNA:SNPs:exon:rs1051740, rs2234922 (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations:exon:p.Y113H, p.H139R (human) DNA:polymorphism
CTD
PMID:29605894 , PMID:22200898 , PMID:11849215 , PMID:20731606
RGD:11252114 , RGD:11252119 , RGD:11252115
NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment no_association
ISO
DNA:polymorphism: :p.R399Q (human) DNA:SNP: :p.Q504K (human)
RGD
PMID:18604718 , PMID:23397959 , PMID:16507781 , PMID:20141440 , PMID:21942242
RGD:11252170 , RGD:11252193 , RGD:11252179 , RGD:11252173 , RGD:11252171
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
disease_progression no_association
ISO
DNA:polymorphism: :p.K751Q (rs13181) (human) DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human) associated with Myeloproliferative Disorders;DNA:polymorphism: :p.K751Q (rs13181) (human)
RGD
PMID:20141440 , PMID:21394217 , PMID:22496165 , PMID:23397959
RGD:11252173 , RGD:11252209 , RGD:11252198 , RGD:11252193
NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
G
Erg
ETS transcription factor ERG
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19822134
NCBI chr11:35,645,317...35,749,637
Ensembl chr11:35,646,116...35,749,594
G
Etv6
ETS variant transcription factor 6
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia DNA:translocation: : DNA:deletion: : DNA:translocation: :t(5;12)(q31;p13) (human) ClinVar Annotator: match by term: Leukemia, acute myeloid, UMLS MESH term: Acute Myelogenous Leukemia
OMIM ClinVar
PMID:15806161 PMID:25581430 PMID:25807284 PMID:31248877 , PMID:12161353 , PMID:9171997 , PMID:10502316
RGD:10450603 , RGD:10450601 , RGD:1599805
NCBI chr 4:167,754,684...167,992,370
Ensembl chr 4:167,754,525...167,992,168
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
disease_progression susceptibility
ISO
mRNA:increased expression:bone marrow, mononuclear cell (human) DNA:mutations:cds:multiple (human)
RGD
PMID:22677129 , PMID:21125401 , PMID:23099237
RGD:10450874 , RGD:10450887 , RGD:10450876
NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
G
F3
coagulation factor III, tissue factor
ISO
RGD
PMID:2617479
RGD:11340207
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
G
Fadd
Fas associated via death domain
disease_progression
ISO
RGD
PMID:15520222
RGD:11341799
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
G
Fanca
FA complementation group A
ISO
DNA, mRNA:deletions, decreased expression: :multiple
RGD
PMID:14749703
RGD:11344889
NCBI chr19:56,067,548...56,126,075
Ensembl chr19:56,067,548...56,126,063
G
Fancc
FA complementation group C
susceptibility
ISO
DNA:polymorphism:cds:p.S26F (human)
RGD
PMID:12670332
RGD:11046259
NCBI chr17:826,512...955,703
Ensembl chr17:833,509...955,615
G
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism, haplotype:promoter:-1377 G>A, -670 G>A (human) CTD Direct Evidence: marker/mechanism
CTD
PMID:7579353 , PMID:12907599 , PMID:8870373
RGD:11049150 , RGD:11049452
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Fermt2
FERM domain containing kindlin 2
disease_progression
ISO
RGD
PMID:22391155
RGD:11352307
NCBI chr15:19,807,806...19,876,557
Ensembl chr15:19,807,808...19,876,408
G
Fermt3
FERM domain containing kindlin 3
disease_progression
ISO
RGD
PMID:22391155
RGD:11352307
NCBI chr 1:222,254,183...222,272,775
Ensembl chr 1:222,254,184...222,272,285
G
Fgfr1
Fibroblast growth factor receptor 1
treatment
ISO
RGD
PMID:27005999 , PMID:23777766 , PMID:22683780
RGD:11352310 , RGD:11352670 , RGD:11352665
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
G
Fhl2
four and a half LIM domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 9:49,920,611...49,994,906
Ensembl chr 9:49,920,854...49,950,093
G
Flt3
Fms related receptor tyrosine kinase 3
treatment disease_progression
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid, reduced survival in, somatic CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar Annotator: match by term: Acute myeloid leukemia DNA:missense mutation:exon:p.D835Y,D835H(human) DNA:mutations:cds: DNA:duplication mutation:cds: mRNA,protein:increased expression:bone marrow: ClinVar Annotator: match by term: Leukemia, acute myeloid, UMLS MESH term: Acute Myelogenous Leukemia
ClinVar CTD OMIM
PMID:11091200 PMID:11290608 PMID:11442493 PMID:12384447 PMID:14604974 PMID:14670924 PMID:14737077 PMID:15256420 PMID:15374878 PMID:15625552 PMID:15667533 PMID:15863200 PMID:16091740 PMID:16371029 PMID:16410449 PMID:16573742 PMID:16857985 PMID:16990784 PMID:17047150 PMID:17050201 PMID:17184839 PMID:17387224 PMID:17606455 PMID:17889720 PMID:17942876 PMID:19602710 PMID:19657110 PMID:19822134 PMID:19840437 PMID:20733134 PMID:21441929 PMID:21482694 PMID:21928377 PMID:22368270 PMID:22409268 PMID:22504183 PMID:22504184 PMID:22504185 PMID:22504186 PMID:23036488 PMID:23261068 PMID:23321257 PMID:23430109 PMID:23714533 PMID:23783394 PMID:23878140 PMID:23906301 PMID:24046014 PMID:24526162 PMID:24619500 PMID:25053825 PMID:25157968 PMID:27099147 PMID:27992414 , PMID:11290608 , PMID:11442493 , PMID:23969938 , PMID:24184354 , PMID:16642044 , PMID:8562934
RGD:1598955 , RGD:11049497 , RGD:11049482 , RGD:11049471 , RGD:11049467 , RGD:11049466
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Foxo1
forkhead box O1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 2:141,451,234...141,527,016
Ensembl chr 2:141,451,234...141,527,016
G
Fxyd6
FXYD domain-containing ion transport regulator 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 8:49,676,520...49,703,419
Ensembl chr 8:49,676,540...49,703,419
G
Gas2l1
growth arrest-specific 2 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr14:85,308,443...85,318,475
Ensembl chr14:85,308,443...85,318,194
G
Gata1
GATA binding protein 1
disease_progression
ISO
RGD
PMID:7579412
RGD:10450754
NCBI chr X:15,273,937...15,281,759
Ensembl chr X:15,378,789...15,382,066
G
Gata2
GATA binding protein 2
disease_progression
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid, susceptibility to ClinVar Annotator: match by term: Acute myeloid leukemia CTD Direct Evidence: marker/mechanism mRNA:decreased expression:CD34+ bone marrow cell:
OMIM ClinVar CTD
PMID:20040766 PMID:21242295 PMID:21670465 PMID:21765025 PMID:21892158 PMID:21892162 PMID:22147895 PMID:23365458 PMID:25676417 PMID:25741868 PMID:28492532 , PMID:22786876 , PMID:24514424 , PMID:25241285
RGD:11049515 , RGD:11049514 , RGD:11049510
NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
G
Gfi1
growth factor independent 1 transcriptional repressor
susceptibility
ISO
DNA:SNP:cds:c.107G>A(rs34631763)(human) CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099 , PMID:20075157
RGD:11040450
NCBI chr14:3,058,035...3,073,332
Ensembl chr14:3,058,993...3,068,371
G
Gfi1b
growth factor independent 1B transcriptional repressor
ISO
mRNA:increased expression:bone marrow cell:
RGD
PMID:17156408
RGD:11040507
NCBI chr 3:7,190,721...7,203,444
Ensembl chr 3:7,190,722...7,203,420
G
Gpi
glucose-6-phosphate isomerase
ISO
protein:increased expression:plasma:
RGD
PMID:6589021
RGD:11051848
NCBI chr 1:90,063,411...90,091,287
Ensembl chr 1:90,063,411...90,091,287
G
Gpx1
glutathione peroxidase 1
disease_progression treatment susceptibility
ISO
DNA:SNP: :c.599C>T (rs1050450) (human) DNA:polymorphism: :p.P198L (human)
RGD
PMID:26950655 , PMID:22930375 , PMID:26823947
RGD:11061784 , RGD:11352817 , RGD:11061561
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
G
Gskip
GSK3B interacting protein
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid
ClinVar
NCBI chr 6:129,512,950...129,536,320
Ensembl chr 6:129,519,709...129,536,221
G
Gsr
glutathione-disulfide reductase
ISO
RGD
PMID:24191316
RGD:11059506
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
G
Gstm1
glutathione S-transferase mu 1
susceptibility disease_progression
ISO
DNA:methylation: : DNA:deletion: : (human)
RGD
PMID:11488937 , PMID:22924777 , PMID:18035413
RGD:10450822 , RGD:10755405 , RGD:10755318
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
chemotherapy-induced; DNA:polymorphism:cds:p.I105V(human)
RGD
PMID:11553769 , PMID:11906705 , PMID:21729529
RGD:10755420 , RGD:10755328 , RGD:10755422
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
Gstt1
glutathione S-transferase theta 1
no_association disease_progression susceptibility
ISO
RGD
PMID:9164324 , PMID:18035413 , PMID:11488937
RGD:10450779 , RGD:10755318 , RGD:10450822
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
G
Gtf2i
general transcription factor II I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr12:25,410,804...25,487,970
Ensembl chr12:25,411,207...25,488,156
G
H1f0
H1.0 linker histone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 7:120,260,776...120,262,636
G
H1f2
H1.2 linker histone, cluster member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr17:43,638,938...43,640,445
Ensembl chr17:43,639,749...43,640,387
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22683780
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Hmox1
heme oxygenase 1
IEP
mRNA:increased expression:brain, spleen
RGD
PMID:19268504
RGD:10755700
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hoxa9
homeobox A9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22541086
G
Hras
HRas proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar Annotator: match by term: Acute myelogenous leukemia ClinVar Annotator: match by term: Acute myelocytic leukemia ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25914166 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31394527 PMID:31775759 PMID:168335863
NCBI chr 1:214,178,404...214,181,841
Ensembl chr 1:214,178,407...214,181,686
G
Hspb1
heat shock protein family B (small) member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
G
Id2
inhibitor of DNA binding 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 6:44,360,077...44,361,908
Ensembl chr 6:44,348,501...44,363,915
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
disease_progression
ISO
DNA:mutation:cds:p.R132(human) ClinVar Annotator: match by term: Acute myelocytic leukemia ClinVar Annotator: match by term: Acute myelogenous leukemia CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar Annotator: match by term: Acute myeloid leukemia DNA:SNP::105C>T (rs11554137)(human)
ClinVar CTD
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25324972 PMID:25741868 PMID:26619011 PMID:27992414 , PMID:20368543 , PMID:25324972
RGD:11522718 , RGD:11522721
NCBI chr 9:71,882,108...71,911,645
Ensembl chr 9:71,882,105...71,900,044
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
disease_progression
ISO
DNA:mutation:cds:p.R172(human) ClinVar Annotator: match by term: Acute myelogenous leukemia CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar Annotator: match by term: Leukemia, acute myelogenous DNA:mutation:cds:p.R140 (human)
ClinVar CTD
PMID:20171147 PMID:20847235 PMID:20946881 PMID:21250968 PMID:21596855 PMID:21889589 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23558173 PMID:23815907 PMID:23949315 PMID:24049096 PMID:24606448 PMID:25157968 PMID:25324972 PMID:25326635 PMID:25398939 PMID:25741868 PMID:26619011 PMID:27992414 PMID:28492532 , PMID:20368543 , PMID:25324972
RGD:11522718 , RGD:11522721
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
G
Ifi30
IFI30, lysosomal thiol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr16:20,426,566...20,430,772
Ensembl chr16:20,426,566...20,430,752
G
Il10
interleukin 10
disease_progression
ISO
RGD
PMID:23357299
RGD:11046264
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il1a
interleukin 1 alpha
treatment
ISO
RGD
PMID:2460157
RGD:11051965
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
G
Il4r
interleukin 4 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11918534
NCBI chr 1:196,942,343...196,967,221
Ensembl chr 1:196,942,364...196,967,220
G
Il6
interleukin 6
disease_progression treatment
ISO
human protein in a rat model
RGD
PMID:23357299 , PMID:8892684
RGD:11046264 , RGD:11062010
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Inpp4b
inositol polyphosphate-4-phosphatase type II B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29415082
NCBI chr19:29,592,889...30,341,528
Ensembl chr19:29,597,905...29,968,424
G
Insl6
insulin-like 6
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid ClinVar Annotator: match by term: Acute myelogenous leukemia
ClinVar
PMID:15781101 PMID:15793561 PMID:15858187 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:32581362
NCBI chr 1:247,473,292...247,476,827
Ensembl chr 1:247,473,292...247,476,827
G
Itgav
integrin subunit alpha V
treatment
ISO
RGD
PMID:23770013
RGD:10755448
NCBI chr 3:71,113,269...71,205,958
Ensembl chr 3:71,114,100...71,202,411
G
Itgb3
integrin subunit beta 3
treatment
ISO
RGD
PMID:23770013 , PMID:23770013
RGD:10755448 , RGD:10755448
NCBI chr10:92,667,869...92,783,413
Ensembl chr10:92,667,869...92,783,410
G
Jak1
Janus kinase 1
ISO
ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar
PMID:16239216 PMID:19139102 PMID:19470474 PMID:19838194 PMID:21436584 PMID:21680795
NCBI chr 5:119,982,503...120,091,452
Ensembl chr 5:119,982,943...120,083,904
G
Jak2
Janus kinase 2
ISO
ClinVar Annotator: match by term: Acute myelogenous leukemia CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Leukemia, acute myeloid, UMLS MESH term: Acute Myelogenous Leukemia
OMIM ClinVar CTD
PMID:15781101 PMID:15793561 PMID:15858187 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:32581362
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
G
Kat6a
lysine acetyltransferase 6A
ISO
human gene in a mouse model;DNA:translocation:exon
RGD
PMID:12676584
RGD:9590334
NCBI chr16:73,942,669...74,020,750
Ensembl chr16:73,943,455...74,023,005
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Acute myelocytic leukemia ClinVar Annotator: match by term: Acute myeloid leukemia
OMIM ClinVar
PMID:7479840 PMID:7513208 PMID:7691885 PMID:8589724 PMID:9657776 PMID:9827716 PMID:9990072 PMID:11380399 PMID:11493470 PMID:15685537 PMID:15790786 PMID:15972446 PMID:16352739 PMID:16384925 PMID:16731599 PMID:16741525 PMID:16912224 PMID:17259998 PMID:17699867 PMID:18024392 PMID:18986703 PMID:19164557 PMID:19262599 PMID:19865100 PMID:21642685 PMID:21689725 PMID:22504184 PMID:22932406 PMID:23149070 PMID:23582185 PMID:23714533 PMID:24045550 PMID:25157968 PMID:25741868 PMID:26158763 PMID:26822237 PMID:27777718 PMID:28492532
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
G
Klf1
Kruppel like factor 1
disease_progression
ISO
RGD
PMID:19097174
RGD:10769344
NCBI chr19:26,016,289...26,019,557
Ensembl chr19:26,016,382...26,019,553
G
Kmt2a
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10339604 PMID:26237430 , PMID:8361504
RGD:1625285
NCBI chr 8:49,110,407...49,185,872
Ensembl chr 8:49,114,990...49,158,971
G
Kmt2b
lysine methyltransferase 2B
susceptibility
ISO
RGD
PMID:25079327
RGD:9588599
NCBI chr 1:89,022,889...89,042,176
Ensembl chr 1:89,023,200...89,042,176
G
Kmt2c
lysine methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24794707
NCBI chr 4:82,506...109,986 NCBI chr 4:6,083,650...6,294,413
Ensembl chr 4:6,083,736...6,292,516
G
Kras
KRAS proto-oncogene, GTPase
ISO
OMIM:601626 ClinVar Annotator: match by term: Acute myeloblastic leukemia ClinVar Annotator: match by term: Acute myelogenous leukemia ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar Annotator: match by term: Leukemia, acute myeloid, UMLS MESH term: Acute Myelogenous Leukemia
ClinVar OMIM
PMID:2278970 PMID:2547513 PMID:3122217 PMID:3627975 PMID:7773929 PMID:8439212 PMID:8955068 PMID:12460918 PMID:15696205 PMID:15842656 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17332249 PMID:17384584 PMID:17704260 PMID:17910045 PMID:18316791 PMID:18794081 PMID:19018267 PMID:19029981 PMID:19047918 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19358724 PMID:19679400 PMID:19773371 PMID:19881948 PMID:20609353 PMID:20805368 PMID:20921462 PMID:20921465 PMID:20949522 PMID:20978259 PMID:21063026 PMID:21079152 PMID:21169357 PMID:21228335 PMID:21398618 PMID:21975775 PMID:22025163 PMID:22235099 PMID:22392911 PMID:22407852 PMID:22499344 PMID:22571758 PMID:22683711 PMID:22722830 PMID:22734028 PMID:22897852 PMID:23014527 PMID:23096712 PMID:23182985 PMID:23325582 PMID:23406027 PMID:24033266 PMID:24558511 PMID:24720724 PMID:25044103 PMID:25157968 PMID:25695684 PMID:25705018 PMID:25741868 PMID:25808193 PMID:26372703 PMID:26619011 PMID:26623049 PMID:28492532 PMID:29298116 PMID:31891627 PMID:32581362 , PMID:8955068 , PMID:21283084
RGD:1600469 , RGD:11060151
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
LOC100909954
uncharacterized LOC100909954
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid
ClinVar
NCBI chr 6:129,259,581...129,322,113
G
Lpar1
lysophosphatidic acid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 5:75,557,038...75,678,067
Ensembl chr 5:75,557,042...75,676,584
G
Lpp
LIM domain containing preferred translocation partner in lipoma
ISO
OMIM
NCBI chr11:79,192,603...79,827,858
Ensembl chr11:79,205,730...79,703,736
G
Lrrc56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar Annotator: match by term: Acute myelogenous leukemia ClinVar Annotator: match by term: Acute myelocytic leukemia
ClinVar
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25914166 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31394527 PMID:31775759 PMID:168335863
NCBI chr 1:214,182,232...214,197,184
Ensembl chr 1:214,182,830...214,197,184
G
Lyl1
LYL1, basic helix-loop-helix family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16094422
NCBI chr19:25,815,207...25,818,074
Ensembl chr19:25,815,207...25,818,074
G
Mdm2
MDM2 proto-oncogene
disease_progression
ISO
RGD
PMID:11064355
RGD:11251749
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
G
Mecom
MDS1 and EVI1 complex locus
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30472098
NCBI chr 2:117,396,084...117,993,604
Ensembl chr 2:117,396,007...117,454,769
G
Mefv
MEFV innate immuity regulator, pyrin
susceptibility
ISO
DNA:polymorphisms:cds:p.M694V,E148Q(human)
RGD
PMID:22351163
RGD:11531114
NCBI chr10:12,045,813...12,056,229
Ensembl chr10:12,046,541...12,056,311
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22683780
NCBI chr 4:44,747,467...44,854,628
Ensembl chr 4:44,774,741...44,852,665
G
Mir155
microRNA 155
ISO
miRNA:increased expression:blood miRNA:decreased expression:peripheral blood mononuclear cell
RGD
PMID:28989535 , PMID:26923190
RGD:24922214 , RGD:25671477
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
G
Mlf1
myeloid leukemia factor 1
ISO
RGD
PMID:15659732
RGD:1600902
NCBI chr 2:164,549,423...164,582,645
Ensembl chr 2:164,549,455...164,582,643
G
Mllt10
MLLT10, histone lysine methyltransferase DOT1L cofactor
ISO
OMIM
NCBI chr17:84,847,660...84,981,134
Ensembl chr17:84,881,414...84,979,543
G
Mn1
MN1 proto-oncogene, transcriptional regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19822134
NCBI chr12:51,214,192...51,250,230
Ensembl chr12:51,214,192...51,250,230
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:17156840
RGD:10449408
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:polymorphism: :66A>G(human)
RGD
PMID:18774170
RGD:11075096
NCBI chr 1:37,743,089...37,774,485
Ensembl chr 1:37,743,147...37,774,015
G
Mx2
MX dynamin like GTPase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr11:38,035,306...38,066,185
Ensembl chr11:38,035,450...38,059,950
G
Mybl2
MYB proto-oncogene like 2
ISS
OMIM:601626
MouseDO
NCBI chr 3:159,421,638...159,450,087
Ensembl chr 3:159,421,671...159,450,086
G
Myc
MYC proto-oncogene, bHLH transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25956709
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Myh11
myosin heavy chain 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229 PMID:27798625
NCBI chr10:764,421...859,184
Ensembl chr10:764,421...859,184
G
Nat2
N-acetyltransferase 2
susceptibility no_association
ISO
DNA:polymorphisms,haplotype: : DNA:polymorphism: :
RGD
PMID:21888617 , PMID:11352872
RGD:11532769 , RGD:11532773
NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
G
Ncoa2
nuclear receptor coactivator 2
ISO
human gene in a mouse model;DNA:translocation:exon
RGD
PMID:12676584
RGD:9590334
NCBI chr 5:5,466,544...5,696,540
Ensembl chr 5:5,616,483...5,694,598
G
Nectin2
nectin cell adhesion molecule 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29855615
NCBI chr 1:80,631,449...80,666,617
Ensembl chr 1:80,631,450...80,666,585
G
Nf1
neurofibromin 1
severity disease_progression
ISO
CTD Direct Evidence: marker/mechanism DNA:deletion: :
CTD
PMID:21441929 PMID:25822087 , PMID:23460398 , PMID:12518368
RGD:12789444 , RGD:12754447
NCBI chr10:66,732,460...66,928,706
Ensembl chr10:66,690,133...66,928,903
G
Nos3
nitric oxide synthase 3
disease_progression
ISO
DNA:polymorphgism: : 894 G>T(human)
RGD
PMID:24684492
RGD:11533640
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
G
Npm1
nucleophosmin 1
onset disease_progression
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia CTD Direct Evidence: marker/mechanism DNA:mutation:exon: ClinVar Annotator: match by term: Leukemia, acute myeloid, UMLS MESH term: Acute Myelogenous Leukemia
ClinVar CTD OMIM
PMID:15659725 PMID:19657110 PMID:19822134 PMID:20026798 PMID:21441929 PMID:23877794 PMID:27992414 PMID:30420649 PMID:32581362 , PMID:15659725 , PMID:21441929 , PMID:25992555 , PMID:17957027 , PMID:24184354 , PMID:15659732
RGD:1600907 , RGD:11534990 , RGD:11070453 , RGD:11049474 , RGD:11049471 , RGD:1600902
NCBI chr10:18,080,949...18,091,062
Ensembl chr10:18,080,950...18,090,950
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
DNA:SNP: :609C>T (human)
RGD
PMID:19456854
RGD:10769358
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nras
NRAS proto-oncogene, GTPase
disease_progression
ISO
ClinVar Annotator: match by term: Acute myelogenous leukemia CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar Annotator: match by term: Acute myeloid leukemia DNA:missense mutation:cds:
ClinVar CTD
PMID:1654209 PMID:2278970 PMID:2407301 PMID:2674680 PMID:2989702 PMID:3102434 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10598665 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:14982869 PMID:15046639 PMID:15831708 PMID:15899789 PMID:15951308 PMID:16273091 PMID:16291983 PMID:16434492 PMID:16518851 PMID:17332249 PMID:17384584 PMID:17517660 PMID:17699718 PMID:18375819 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18794081 PMID:18948947 PMID:18952898 PMID:19047918 PMID:19075190 PMID:19657110 PMID:19775298 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21079152 PMID:21107323 PMID:21263000 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22144181 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:22962325 PMID:23076151 PMID:23134356 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23431193 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24284627 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:26619011 PMID:26821351 PMID:27050078 PMID:27992414 PMID:28098151 PMID:28492532 PMID:28594414 PMID:28780248 , PMID:21283084 , PMID:18952898 , PMID:25204082
RGD:11060151 , RGD:11070616 , RGD:11535045
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Nsd1
nuclear receptor binding SET domain protein 1
severity
ISO
DNA:translocations:multiple (human)
RGD
PMID:23630019
RGD:9590149
NCBI chr17:9,840,859...9,955,391
Ensembl chr17:9,844,133...9,952,898
G
Ntrk3
neurotrophic receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29119387
NCBI chr 1:139,890,537...140,262,503
Ensembl chr 1:139,890,560...140,262,503
G
Nup214
nucleoporin 214
ISO
OMIM
NCBI chr 3:9,227,869...9,236,878 NCBI chr 3:10,993,584...11,070,638
Ensembl chr 3:9,227,823...9,236,736 Ensembl chr 3:9,227,823...9,236,736
G
Nup98
nucleoporin 98 and 96 precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21441929
NCBI chr 1:167,213,866...167,308,851
Ensembl chr 1:167,213,866...167,308,851
G
Pax5
paired box 5
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:25741868
NCBI chr 5:60,007,587...60,191,973
Ensembl chr 5:60,007,587...60,191,941
G
Pdcd1
programmed cell death 1
treatment
ISO
RGD
PMID:26712908
RGD:41410789
NCBI chr 9:101,305,742...101,319,937
Ensembl chr 9:101,307,764...101,319,845
G
Pde4b
phosphodiesterase 4B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 5:121,759,236...122,136,814
Ensembl chr 5:121,952,977...122,136,814
G
Picalm
phosphatidylinositol binding clathrin assembly protein
susceptibility
ISO
DNA:inversion: :inv(11)(q14q23)
OMIM
PMID:12461747
RGD:1600760
NCBI chr 1:154,377,229...154,458,966
Ensembl chr 1:154,377,247...154,458,425
G
Pim2
Pim-2 proto-oncogene, serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19458359
NCBI chr X:15,462,621...15,467,890
Ensembl chr X:15,462,016...15,467,875
G
Plcb1
phospholipase C beta 1
severity
ISO
mRNA:increased expression:blood (human)
RGD
PMID:20516454
RGD:11535940
NCBI chr 3:127,721,244...128,419,565
Ensembl chr 3:128,155,069...128,419,545
G
Pou4f1
POU class 4 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr15:88,618,255...88,622,712
Ensembl chr15:88,620,470...88,622,413
G
Prame
PRAME nuclear receptor transcriptional regulator
ISO
mRNA:increased expression:bone marrow, mononuclear cell (human)
RGD
PMID:20376794
RGD:11535023
NCBI chr X:106,082,984...106,091,256
Ensembl chr X:106,083,203...106,085,878
G
Psip1
PC4 and SFRS1 interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 5:101,555,691...101,588,659
Ensembl chr 5:101,555,694...101,588,598
G
Ptch1
patched 1
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:28873162
NCBI chr17:1,032,242...1,085,885
Ensembl chr17:1,029,048...1,093,873
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
ISO
ClinVar Annotator: match by term: Leukemia, acute myelogenous ClinVar Annotator: match by term: Acute myeloid leukemia CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:12717436 PMID:14644997 PMID:15385933 PMID:15710330 PMID:15928039 PMID:16358218 PMID:17972951 PMID:19047918 PMID:19179468 PMID:24033266 PMID:25097206 PMID:25395418 PMID:26619011 PMID:27069254 PMID:27992414 PMID:28098151 PMID:30868567
NCBI chr12:40,895,515...40,955,999
Ensembl chr12:40,895,515...40,955,999
G
Pvr
PVR cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29855615
NCBI chr 1:80,820,306...80,835,712
Ensembl chr 1:80,820,050...80,835,701
G
Pxdn
peroxidasin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 6:48,866,496...48,982,368
Ensembl chr 6:48,866,601...48,980,340
G
Rasgrp1
RAS guanyl releasing protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21441929
NCBI chr 3:108,984,029...109,044,420
Ensembl chr 3:108,984,029...109,044,420
G
Rgs2
regulator of G-protein signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr13:60,846,458...60,849,061
Ensembl chr13:60,846,308...60,849,094
G
RT1-Bb
RT1 class II, locus Bb
ISO
RGD
PMID:20051322 , PMID:17237562
RGD:11041763 , RGD:11041776
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
G
Rtel1
regulator of telomere elongation helicase 1
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:25741868
NCBI chr 3:176,818,012...176,856,531
Ensembl chr 3:176,818,437...176,856,531
G
Runx1
RUNX family transcription factor 1
disease_progression
ISO
DNA:translocation ClinVar Annotator: match by term: Acute myeloid leukemia CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Leukemia, acute myeloid, m0 subtype DNA:frameshift mutations, missense mutations, nonsense mutations: :multiple
ClinVar CTD OMIM
PMID:10068652 PMID:10508512 PMID:12200707 PMID:12807882 PMID:15156185 PMID:17234761 PMID:18206229 PMID:19357396 PMID:19387465 PMID:20549580 PMID:22012064 PMID:23817177 PMID:24374719 PMID:24523240 PMID:24616160 PMID:24659740 PMID:25741868 PMID:25840971 PMID:27798625 PMID:28492532 PMID:28513614 PMID:30420649 PMID:31064749 , PMID:12760263 , PMID:19808697 , PMID:11023523
RGD:6482833 , RGD:11251704 , RGD:11251692
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229 PMID:27798625
NCBI chr 5:27,284,921...27,440,802
Ensembl chr 5:27,312,928...27,442,841
G
Runx3
RUNX family transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr 5:153,507,093...153,531,137
Ensembl chr 5:153,507,093...153,531,137
G
S100a10
S100 calcium binding protein A10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 2:193,892,589...193,901,236
Ensembl chr 2:193,892,589...193,901,236
G
S100a8
S100 calcium binding protein A8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21971985
NCBI chr 2:190,073,239...190,074,333
Ensembl chr 2:190,073,815...190,074,354
G
Septin9
septin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10339604
NCBI chr10:106,208,308...106,340,747
Ensembl chr10:106,264,434...106,348,490
G
Sf3b1
splicing factor 3b, subunit 1
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar
PMID:21909114 PMID:21995386 PMID:23395771 PMID:23634996 PMID:26619011
NCBI chr 9:61,594,620...61,634,510
Ensembl chr 9:61,594,620...61,634,510
G
Sf3b2
splicing factor 3b, subunit 2
ISO
ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar
PMID:26619011
NCBI chr 1:220,645,685...220,665,611
Ensembl chr 1:220,645,672...220,665,603
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 1:24,185,451...24,302,309
Ensembl chr 1:24,185,435...24,302,298
G
Sh3gl1
SH3 domain containing GRB2 like 1, endophilin A2
ISO
OMIM
NCBI chr 9:11,031,847...11,055,285
Ensembl chr 9:11,031,841...11,055,285
G
Sod2
superoxide dismutase 2
disease_progression
ISO
protein:increased expression:serum
RGD
PMID:1596865 , PMID:16769586
RGD:11035286 , RGD:11035289
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
G
Sparc
secreted protein acidic and cysteine rich
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
G
Spi1
Spi-1 proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26237430
NCBI chr 3:79,918,127...79,937,708
Ensembl chr 3:79,918,969...79,938,301
G
Spry4
sprouty RTK signaling antagonist 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822087
NCBI chr18:32,593,370...32,609,890
Ensembl chr18:32,594,958...32,609,864
G
Srsf2
serine and arginine rich splicing factor 2
severity
ISO
DNA:mutations:multiple (human)
RGD
PMID:22431577
RGD:11039017
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
G
Srsf4
serine and arginine rich splicing factor 4
ISO
mRNA:decreased expression: (human)
RGD
PMID:22722453
RGD:11039059
NCBI chr 5:150,032,999...150,060,769
Ensembl chr 5:150,032,999...150,060,765
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19796711
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Svil
supervillin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr17:55,230,298...55,425,967
Ensembl chr17:55,230,298...55,346,279
G
Syngr1
synaptogyrin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 7:121,311,008...121,334,437
Ensembl chr 7:121,311,024...121,334,437
G
Tcea2
transcription elongation factor A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr 3:177,187,686...177,195,898
Ensembl chr 3:177,188,044...177,195,894
G
Tcl1a
Tcl1 family Akt coactivator A
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid
ClinVar
NCBI chr 6:128,888,768...128,894,761
Ensembl chr 6:128,888,768...128,894,761
G
Tcn2
transcobalamin 2
ISO
protein:increased expression::
RGD
PMID:1059479
RGD:11060122
NCBI chr14:84,173,992...84,189,299
Ensembl chr14:84,174,138...84,189,266
G
Tek
TEK receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:19340004
NCBI chr 5:113,725,717...113,852,799
Ensembl chr 5:113,725,717...113,852,799
G
Tert
telomerase reverse transcriptase
disease_progression
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid, susceptibility to ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar Annotator: match by term: Acute myelocytic leukemia
OMIM ClinVar
PMID:15814878 PMID:17460043 PMID:18460650 PMID:18753630 PMID:18931339 PMID:19147845 PMID:19760749 PMID:19796246 PMID:20966039 PMID:21520173 PMID:21635204 PMID:22476886 PMID:23538340 PMID:23901009 PMID:24033266 PMID:24983628 PMID:25108601 PMID:25741868 PMID:26859482 PMID:28154186 PMID:28492532 , PMID:23826993
RGD:11038655
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
G
Tet2
tet methylcytosine dioxygenase 2
disease_progression
ISO
DNA:deletions
RGD
PMID:23389918 , PMID:25200248
RGD:11038681 , RGD:11038682
NCBI chr 2:238,719,389...238,802,975
Ensembl chr 2:238,720,835...238,803,024
G
Tfpi2
tissue factor pathway inhibitor 2
ISO
DNA:hypermethylation:promoter:
RGD
PMID:22052167
RGD:11060127
NCBI chr 4:28,947,951...28,953,261
Ensembl chr 4:28,947,965...28,953,067
G
Tfr2
transferrin receptor 2
disease_progression
ISO
RGD
PMID:15015967
RGD:11062090
NCBI chr12:22,177,382...22,194,330
Ensembl chr12:22,177,382...22,194,299
G
Tgm6
transglutaminase 6
ISO
ClinVar Annotator: match by term: Leukemia, acute myeloid, UMLS MESH term: Acute Myelogenous Leukemia
ClinVar
PMID:21106500
NCBI chr 3:122,644,183...122,680,054
Ensembl chr 3:122,662,086...122,679,128
G
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:20923864 PMID:25741868 PMID:28492532
NCBI chr 3:119,677,575...119,690,371
Ensembl chr 3:119,677,575...119,690,366
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12780785
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
G
Tnfsf8
TNF superfamily member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9058727 PMID:10512160 PMID:11918534
NCBI chr 5:79,664,779...79,691,547
Ensembl chr 5:79,664,765...79,691,258
G
Tnfsf9
TNF superfamily member 9
ISO
protein:increased expression:serum (human)
RGD
PMID:11564827
RGD:2317350
NCBI chr 9:9,909,942...9,912,276
Ensembl chr 9:9,909,948...9,912,276
G
Tp53
tumor protein p53
disease_progression treatment
ISO
DNA:mutation: : ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar Annotator: match by term: Acute myelogenous leukemia ClinVar Annotator: match by term: Acute myelocytic leukemia ClinVar Annotator: match by term: Leukemia, acute myelogenous CTD Direct Evidence: marker/mechanism DNA:mutations: :
ClinVar CTD
PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1631137 PMID:1631151 PMID:1683921 PMID:1978757 PMID:2046748 PMID:2113594 PMID:2826609 PMID:7732013 PMID:7887414 PMID:7969167 PMID:8023157 PMID:8062826 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8423216 PMID:8425176 PMID:8479749 PMID:8527048 PMID:8633021 PMID:9047394 PMID:9049183 PMID:9242456 PMID:9290701 PMID:9407971 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9627118 PMID:9662334 PMID:9825943 PMID:10411893 PMID:10432928 PMID:10589545 PMID:10616528 PMID:10797439 PMID:10864200 PMID:10914716 PMID:10922393 PMID:11051239 PMID:11139324 PMID:11180592 PMID:11315715 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11494139 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11920959 PMID:12124823 PMID:12509279 PMID:12672316 PMID:12700230 PMID:12726864 PMID:12792784 PMID:12826609 PMID:12917626 PMID:14559903 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15381368 PMID:15390294 PMID:15580553 PMID:15607980 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15951970 PMID:15977174 PMID:16209708 PMID:16288208 PMID:16337994 PMID:16401470 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16633321 PMID:16682957 PMID:16778209 PMID:16818505 PMID:16861262 PMID:17015838 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17540308 PMID:17567834 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17875924 PMID:18307025 PMID:18511570 PMID:18555592 PMID:18685109 PMID:19101993 PMID:19336573 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19462533 PMID:19556618 PMID:19681600 PMID:19834951 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20127978 PMID:20128691 PMID:20308654 PMID:20407015 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20693561 PMID:20805372 PMID:21056685 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21601526 PMID:21761402 PMID:22090360 PMID:22110706 PMID:22114072 PMID:22186996 PMID:22265402 PMID:22427690 PMID:22540896 PMID:22713868 PMID:22811390 PMID:22862161 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22999923 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23265383 PMID:23315175 PMID:23334668 PMID:23538418 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24256616 PMID:24381225 PMID:24395441 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24744791 PMID:24810334 PMID:25157968 PMID:25339994 PMID:25433984 PMID:25503501 PMID:25525159 PMID:25584008 PMID:25587027 PMID:25741868 PMID:25787918 PMID:25822087 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:26014290 PMID:26230955 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26534844 PMID:26554828 PMID:26585234 PMID:26619011 PMID:26659639 PMID:26681312 PMID:26787237 PMID:26822237 PMID:26845104 PMID:27022024 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27501770 PMID:27533082 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27873457 PMID:27895058 PMID:27959731 PMID:28135145 PMID:28152038 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28476805 PMID:28477316 PMID:28492532 PMID:28724667 PMID:28861920 PMID:28975465 PMID:29025599 PMID:29070607 PMID:29324801 PMID:29478780 PMID:29489754 PMID:29752822 PMID:29753700 PMID:29979965 PMID:30076369 PMID:30128536 PMID:30216591 PMID:30224644 PMID:30311369 PMID:30327374 PMID:30352134 PMID:30720243 PMID:30816478 PMID:30840781 PMID:31016814 PMID:31206626 PMID:31300551 PMID:31775759 PMID:32000721 PMID:32295079 , PMID:24836762 , PMID:25412846 , PMID:25573287
RGD:11073714 , RGD:11057925 , RGD:11075071
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Trh
thyrotropin releasing hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr 4:124,110,716...124,113,242
Ensembl chr 4:124,110,716...124,113,242
G
Trio
trio Rho guanine nucleotide exchange factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr 2:80,471,398...80,769,313
Ensembl chr 2:80,473,202...80,667,481
G
Tsc1
TSC complex subunit 1
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia
ClinVar
PMID:25741868
NCBI chr 3:7,219,955...7,269,063
Ensembl chr 3:7,237,192...7,265,145
G
Tsc2
TSC complex subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19250671
NCBI chr10:13,962,006...13,996,684
Ensembl chr10:13,961,947...13,996,584
G
Tubb2a
tubulin, beta 2A class IIa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17330099
NCBI chr17:31,493,145...31,496,827
Ensembl chr17:31,493,107...31,498,651
G
Tyms
thymidylate synthetase
susceptibility
ISO
DNA:repeats,insertion/deletion:5'UTR, 3'UTR:
RGD
PMID:18774170
RGD:11075096
NCBI chr 9:121,918,875...121,931,564
Ensembl chr 9:121,918,947...121,931,564
G
U2af1
U2 small nuclear RNA auxiliary factor 1
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia ClinVar Annotator: match by term: Leukemia, acute myelogenous
ClinVar
PMID:22158538 PMID:23029227 PMID:23861105 PMID:24498085 PMID:26619011
NCBI chr20:10,396,652...10,407,564
Ensembl chr20:10,396,621...10,407,554
G
Vegfa
vascular endothelial growth factor A
disease_progression
ISO
DNA:SNP,haplotype: :(rs3025039),(rs699947),(rs833061)(human)
RGD
PMID:17983459
RGD:13432134
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Vopp1
VOPP1 WW domain binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr 4:88,441,067...88,515,141
Ensembl chr 4:88,441,067...88,515,138
G
Vsig4
V-set and immunoglobulin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18206229
NCBI chr X:65,370,851...65,400,298
Ensembl chr X:65,370,851...65,400,298
G
Wt1
WT1 transcription factor
ISO
ClinVar Annotator: match by term: Acute myeloid leukemia CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:19822134 PMID:24374862 PMID:24422723 PMID:24521058 PMID:24659740 PMID:24667279 PMID:24671364 PMID:25741868 PMID:27992414
NCBI chr 3:95,133,221...95,180,574
Ensembl chr 3:95,133,713...95,180,564
G
Zbtb7a
zinc finger and BTB domain containing 7a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27798625
NCBI chr 7:11,429,266...11,446,119
Ensembl chr 7:11,432,049...11,444,786
G
Zfp91
zinc finger protein 91
IDA
RGD
PMID:12738986
RGD:727221
NCBI chr 1:229,602,499...229,640,906
Ensembl chr 1:229,602,499...229,639,187
G
Arhgap26
Rho GTPase activating protein 26
ISO
juvenile myelomonocytic leukemia, OMIM:607785
RGD
PMID:10908648
RGD:1599311
NCBI chr18:31,807,052...32,557,176
Ensembl chr18:31,812,109...32,207,801
G
Cbfb
core-binding factor subunit beta
susceptibility
ISO
DNA:inversion: ;inv(16)(p13q22) CTD Direct Evidence: marker/mechanism
CTD
PMID:10958941 , PMID:8351518
RGD:1599543
NCBI chr19:37,127,508...37,171,075
Ensembl chr19:37,127,508...37,171,069
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
ISO
RGD
PMID:14681685
RGD:11252167
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Flt3
Fms related receptor tyrosine kinase 3
treatment
ISO
RGD
PMID:22187040
RGD:11049503
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Gmps
guanine monophosphate synthase
ISO
treatment-related acute type M4 myeloid leukemia; chromosomal translocation resulted in a fusion of MLL and GMPS genes
RGD
PMID:11110714
RGD:1598998
NCBI chr 2:154,555,967...154,590,662
Ensembl chr 2:154,555,871...154,590,662
G
Kmt2a
lysine methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8282816
NCBI chr 8:49,110,407...49,185,872
Ensembl chr 8:49,114,990...49,158,971
G
Myh11
myosin heavy chain 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10958941
NCBI chr10:764,421...859,184
Ensembl chr10:764,421...859,184
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr 8:77,559,621...77,599,781
Ensembl chr 8:77,559,624...77,599,781
G
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:148,832,231...148,902,356
Ensembl chr 3:148,837,814...148,900,452
G
Birc5
baculoviral IAP repeat-containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Ccl7
C-C motif chemokine ligand 7
IEP
RGD
PMID:19828696
RGD:5130982
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
G
Cd44
CD44 molecule (Indian blood group)
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Cebpa
CCAAT/enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
G
Cebpe
CCAAT/enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr15:33,356,119...33,357,517
Ensembl chr15:33,355,947...33,358,138
G
Dapk2
death-associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr 8:71,822,107...71,941,941
Ensembl chr 8:71,822,129...71,941,910
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674 , PMID:10726043
RGD:11340216
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr 2:113,109,949...113,415,171
Ensembl chr 2:113,112,902...113,345,577
G
Gli1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 7:70,620,794...70,633,171
Ensembl chr 7:70,620,766...70,630,338
G
Gli2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr13:34,829,021...35,049,172
Ensembl chr13:34,829,139...35,048,444
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
RGD
PMID:21875282
RGD:10755406
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 9:71,882,108...71,911,645
Ensembl chr 9:71,882,105...71,900,044
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 1:141,874,354...141,893,674
Ensembl chr 1:141,866,283...141,893,705
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr19:59,497,021...59,502,298
Ensembl chr19:59,499,876...59,502,161
G
Itgal
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:198,744,053...198,781,745
Ensembl chr 1:198,744,050...198,781,750
G
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
G
Itgax
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:199,555,560...199,576,948
Ensembl chr 1:199,555,722...199,576,932
G
Itgb2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr20:11,777,773...11,815,647
Ensembl chr20:11,777,783...11,815,647
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
G
Kmt2e
lysine methyltransferase 2E
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr 4:8,187,751...8,255,578
Ensembl chr 4:8,187,751...8,255,514
G
Myc
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853 , PMID:21059853
RGD:11532756 , RGD:11532756
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
G
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr 8:53,836,797...54,134,881
Ensembl chr 8:53,839,098...53,901,358
G
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909 , PMID:15659732
RGD:1600902
NCBI chr10:18,080,949...18,091,062
Ensembl chr10:18,080,950...18,090,950
G
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Numa1
nuclear mitotic apparatus protein 1
ISO
OMIM
NCBI chr 1:167,044,544...167,091,453
Ensembl chr 1:167,051,209...167,091,453
G
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
G
Pml
PML nuclear body scaffold
ISO
CTD Direct Evidence: marker/mechanism human PML/RARA gene fusion in a mouse model
CTD
PMID:8616088 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 , PMID:9122233
RGD:41404695
NCBI chr 8:63,002,515...63,034,310
Ensembl chr 8:63,004,870...63,034,226
G
Prame
PRAME nuclear receptor transcriptional regulator
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chr X:106,082,984...106,091,256
Ensembl chr X:106,083,203...106,085,878
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr10:97,940,705...97,959,199
Ensembl chr10:97,940,705...97,957,336
G
Rap1gap
Rap1 GTPase-activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 5:156,008,868...156,074,350
Ensembl chr 5:156,026,911...156,074,395
G
Rara
retinoic acid receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM
PMID:8616088 PMID:10742073 PMID:14508522 PMID:14706140 PMID:16239915 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:17712046 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21613260 PMID:22213200 PMID:23208507 PMID:25583766 PMID:26285909 PMID:26728337 PMID:28314734 , PMID:15659732
RGD:1600902
NCBI chr10:86,838,819...86,884,224
Ensembl chr10:86,860,685...86,884,210
G
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
G
Tet2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:238,719,389...238,802,975
Ensembl chr 2:238,720,835...238,803,024
G
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr 3:142,748,673...142,752,325
Ensembl chr 3:142,748,674...142,752,325
G
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 3:119,677,575...119,690,371
Ensembl chr 3:119,677,575...119,690,366
G
Top2a
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr10:86,901,467...86,930,947
Ensembl chr10:86,901,007...86,932,154
G
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:95,133,221...95,180,574
Ensembl chr 3:95,133,713...95,180,564
G
Zbtb16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23208507 , PMID:8387545
RGD:1599922
NCBI chr 8:52,980,226...53,146,765
Ensembl chr 8:52,985,313...53,146,953
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:15050920
RGD:11352668
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
G
Setbp1
SET binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23222956
NCBI chr18:75,090,733...75,432,446
Ensembl chr18:75,095,632...75,207,306
G
Aicda
activation-induced cytidine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570118
NCBI chr 4:155,359,909...155,371,104
Ensembl chr 4:155,359,921...155,369,671
G
Bcr
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570118
NCBI chr20:14,421,250...14,546,406
Ensembl chr20:14,421,141...14,545,772
G
Esr2
estrogen receptor 2
ISO
RGD
PMID:12740446
RGD:734951
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:22139798
RGD:10755566
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Mir150
microRNA 150
ISO
miRNA:decreased expression:leukocytes
RGD
PMID:21501493
RGD:13782140
NCBI chr 1:101,115,974...101,116,058
Ensembl chr 1:101,115,974...101,116,058
G
Tcn2
transcobalamin 2
ISO
protein:increased expression::
RGD
PMID:1059479
RGD:11060122
NCBI chr14:84,173,992...84,189,299
Ensembl chr14:84,174,138...84,189,266
G
Abcb1a
ATP binding cassette subfamily B member 1A
treatment susceptibility
ISO
DNA:SNPs: :1236T>C,2677G>A(human) DNA:SNP, haplotype: :3435C>T (human)
RGD
PMID:24581936 , PMID:26250462
RGD:11081178 , RGD:11081180
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
G
Abcc2
ATP binding cassette subfamily C member 2
treatment
ISO
DNA:haploltype: :-24C>T, 1249G>A, 3972C>T(human)
RGD
PMID:25060527
RGD:11080961
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
G
Abcg2
ATP binding cassette subfamily G member 2
treatment susceptibility
ISO
DNA:SNP: :421C>A(human) DNA:haplotype:cds: p.Q141K,p.V12M,(rs2231142),(rs2725252)(human) DNA:SNP,haplotype: :C>A421(human)
RGD
PMID:24581936 , PMID:24123600 , PMID:26250462
RGD:11081178 , RGD:11081181 , RGD:11081180
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
susceptibility treatment
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia ClinVar Annotator: match by term: ABL1-Related Disorder DNA:gene fusion ClinVar Annotator: match by term: Chronic myeloid leukemia ClinVar Annotator: match by term: Chronic myeloid leukemia, resistant to imatinib ClinVar Annotator: match by term: Leukemia, philadelphia chromosome-positive, resistant to imatinib CTD Direct Evidence: marker/mechanism DNA:missense mutations: :multiple
ClinVar OMIM CTD
PMID:10988075 PMID:11423618 PMID:11567109 PMID:11569495 PMID:11853795 PMID:11861307 PMID:11964322 PMID:12130516 PMID:12399961 PMID:12576318 PMID:12623848 PMID:12663457 PMID:12783380 PMID:14559829 PMID:14745431 PMID:15194504 PMID:15256422 PMID:15381060 PMID:15510211 PMID:15604220 PMID:17008892 PMID:17114651 PMID:17189410 PMID:18223278 PMID:18354488 PMID:18615627 PMID:18673174 PMID:18757400 PMID:18828913 PMID:19164531 PMID:19264234 PMID:19466505 PMID:19557636 PMID:19652056 PMID:19768693 PMID:19811824 PMID:20010464 PMID:20367437 PMID:20512393 PMID:20537386 PMID:20557306 PMID:20607847 PMID:20697894 PMID:20702476 PMID:20963643 PMID:21221851 PMID:21489624 PMID:21505103 PMID:21509757 PMID:21562040 PMID:21605905 PMID:21762985 PMID:21872826 PMID:21888027 PMID:21895409 PMID:21908430 PMID:22210874 PMID:22306673 PMID:22772060 PMID:22870928 PMID:22912393 PMID:23355941 PMID:23540562 PMID:23575252 PMID:23676790 PMID:24109527 PMID:24236021 PMID:24456693 PMID:25152116 PMID:25157968 PMID:25686603 PMID:28492532 PMID:31775759 , PMID:3021820 , PMID:25133686 , PMID:21481795 , PMID:12067277 , PMID:23289634
RGD:1598673 , RGD:13674161 , RGD:11038814 , RGD:14392796 , RGD:11038807
NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
G
Abl2
ABL proto-oncogene 2, non-receptor tyrosine kinase
TAS
RGD
PMID:7773298
RGD:1298615
NCBI chr13:74,154,533...74,333,244
Ensembl chr13:74,154,835...74,333,244
G
Ace
angiotensin I converting enzyme
ISO
RGD
PMID:19761684
RGD:11039056
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
G
Agt
angiotensinogen
ISO
RGD
PMID:19761684
RGD:11039056
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
G
Akt1
AKT serine/threonine kinase 1
ISO
protein:increased phosphorylation:blood
RGD
PMID:17900686
RGD:13674160
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19503090 PMID:19823023
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
G
Arntl
aryl hydrocarbon receptor nuclear translocator-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 1:178,039,002...178,137,469
Ensembl chr 1:178,039,063...178,137,465
G
Bcl2l1
Bcl2-like 1
ISO
RGD
PMID:20728382
RGD:11353850
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
G
Bcr
BCR activator of RhoGEF and GTPase
susceptibility treatment disease_progression
ISO
DNA:gene fusion BCR/ABL fusion CTD Direct Evidence: marker/mechanism DNA:methylation: : DNA:translocations:cds:
CTD OMIM
PMID:15604220 PMID:18673174 PMID:21908430 , PMID:3101769 , PMID:12613514 , PMID:25133686 , PMID:12067277 , PMID:7683349 , PMID:2683759 , PMID:1362728
RGD:1600510 , RGD:41404631 , RGD:13674161 , RGD:14392796 , RGD:11038783 , RGD:11038776 , RGD:11038775
NCBI chr20:14,421,250...14,546,406
Ensembl chr20:14,421,141...14,545,772
G
Birc5
baculoviral IAP repeat-containing 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16254145
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Chronic myeloid leukemia
ClinVar
PMID:24033266 PMID:24446311 PMID:25157968 PMID:26619011
NCBI chr 4:67,389,331...67,520,549
Ensembl chr 4:67,396,192...67,520,356
G
Ca9
carbonic anhydrase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
G
Cd36
CD36 molecule
ISO
protein:increased expression:platelet, cell surface
RGD
PMID:8555064
RGD:11041099
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
G
Cd40
CD40 molecule
ISO
protein:increased expression:peripheral blood, dendritic cell (human)
RGD
PMID:16527350
RGD:11520794
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
ISO
Protein:increased expression:Blood, common myeloid progenitor, CD34-positive
RGD
PMID:20200561
RGD:13673878
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
treatment
ISO
RGD
PMID:16533530
RGD:11251777
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
treatment
ISO
RGD
PMID:16533530
RGD:11251777
G
Cdkn2a_v2
cyclin-dependent kinase inhibitor 2A, variant 2
treatment
ISO
RGD
PMID:16533530
RGD:11251777
G
Chordc1
cysteine and histidine rich domain containing 1
ISS
OMIM:608232
MouseDO
NCBI chr 8:17,421,552...17,445,513
Ensembl chr 8:17,421,557...17,446,165
G
Crkl
CRK like proto-oncogene, adaptor protein
ISO
protein:increased phosphorylation:blood
RGD
PMID:17900686
RGD:13674160
NCBI chr11:87,338,606...87,356,644
Ensembl chr11:87,778,312...87,815,043
G
Cry1
cryptochrome circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 7:24,534,593...24,634,098
Ensembl chr 7:24,534,615...24,634,097
G
Cry2
cryptochrome circadian regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 3:81,314,151...81,344,143
Ensembl chr 3:81,314,149...81,344,110
G
Csf3r
colony stimulating factor 3 receptor
ISO
ClinVar Annotator: match by term: Chronic myeloid leukemia ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:23604229 PMID:23634996 PMID:23656643 PMID:24081659 PMID:24403076 PMID:24614839 PMID:24854193 PMID:25491280 PMID:25741868 PMID:25932451 PMID:26875968 PMID:27148573 PMID:27581359 PMID:28209919 PMID:28219221 PMID:28492532 PMID:28762112 PMID:30967555
NCBI chr 5:144,031,353...144,051,966
Ensembl chr 5:144,031,402...144,051,600
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
treatment
ISO
DNA:polymorphism:cds:4889A>G(p.I462V)(human)
RGD
PMID:26464823
RGD:11352729
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
susceptibility treatment
ISO
DNA:polymorphism:intron :6986A>G(human) DNA:SNP::rs776746(human)
RGD
PMID:21039054 , PMID:19584153
RGD:11353798 , RGD:11353810
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
G
Dnmt1
DNA methyltransferase 1
disease_progression
ISO
RGD
PMID:11222358
RGD:9588667
NCBI chr 8:21,922,515...21,968,495
Ensembl chr 8:21,922,515...21,968,495
G
Dnmt3a
DNA methyltransferase 3 alpha
disease_progression
ISO
RGD
PMID:11222358
RGD:9588667
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
G
Dnmt3b
DNA methyltransferase 3 beta
disease_progression
ISO
RGD
PMID:11222358
RGD:9588667
NCBI chr 3:149,131,541...149,170,061
Ensembl chr 3:149,131,785...149,208,786
G
E2f1
E2F transcription factor 1
ISO
mRNA:increased expression:blood
RGD
PMID:26460262
RGD:13674165
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
DNA:polymorphism: :p.K751Q (human) DNA:polymorphism: :p.K751Q (rs13181) (human)
RGD
PMID:24955348 , PMID:25311495
RGD:11252188 , RGD:11060463
NCBI chr 1:80,293,574...80,307,334
Ensembl chr 1:80,293,566...80,307,344
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
mRNA:increased expression:bone marrow mononuclear cells (human)
RGD
PMID:27070757
RGD:13782088
NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
G
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphisms, haplotype:promoter: -670 G>A, -1377 G>A (human)
RGD
PMID:26563376
RGD:11049146
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
G
Faslg
Fas ligand
susceptibility
ISO
DNA:polymorphism:promoter: -844 T>C(human)
RGD
PMID:26563376
RGD:11049146
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
G
Fcgr2a
Fc fragment of IgG receptor IIa
ISO
RGD
PMID:8632671
RGD:11344957
NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036 Ensembl chr13:91,168,973...91,198,036
G
Fgfr3
fibroblast growth factor receptor 3
ISO
mRNA:increased expression:peripheral blood (human)
RGD
PMID:14562121
RGD:36947884
NCBI chr14:82,272,322...82,287,739
Ensembl chr14:82,273,070...82,287,706
G
Gab2
GRB2-associated binding protein 2
disease_progression
ISO
protein:increased expression:bone marrow
RGD
PMID:22858987
RGD:13699433
NCBI chr 1:162,082,876...162,283,379
Ensembl chr 1:162,083,030...162,279,727
G
Gpx1
glutathione peroxidase 1
no_association
ISO
DNA:polymorphism: :p.P198L (human)
RGD
PMID:25436036
RGD:11352762
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20843134
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
G
Hes1
hes family bHLH transcription factor 1
IMP
rat gene in a mouse model
RGD
PMID:19861684
RGD:9685380
NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248
G
Hmmr
hyaluronan-mediated motility receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr10:25,861,490...25,890,639
Ensembl chr10:25,861,490...25,890,639
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:22139798
RGD:10755566
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hspa5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23777986
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:20305143
RGD:11049154
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il1b
interleukin 1 beta
severity
ISO
RGD
PMID:7949186
RGD:10450889
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
G
Il1rn
interleukin 1 receptor antagonist
severity
ISO
RGD
PMID:7949186
RGD:10450889
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
G
Insl6
insulin-like 6
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:15781101 PMID:15793561 PMID:15858187 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:32581362
NCBI chr 1:247,473,292...247,476,827
Ensembl chr 1:247,473,292...247,476,827
G
Jak2
Janus kinase 2
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:15781101 PMID:15793561 PMID:15858187 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:32581362
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:16307017 PMID:22703879 PMID:24728327 PMID:25741868 PMID:31775759
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
G
Mapk14
mitogen activated protein kinase 14
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16818652
NCBI chr20:5,933,290...5,995,137
Ensembl chr20:5,933,303...5,995,137
G
Mdm2
MDM2 proto-oncogene
onset
ISO
DNA:SNP:promoter:rs2279744(human)
RGD
PMID:23818300
RGD:13703044
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
G
Mir150
microRNA 150
ISO
miRNA:decreased expression:leukocytes
RGD
PMID:21501493
RGD:13782140
NCBI chr 1:101,115,974...101,116,058
Ensembl chr 1:101,115,974...101,116,058
G
Mlf1
myeloid leukemia factor 1
ISO
RGD
PMID:15659732
RGD:1600902
NCBI chr 2:164,549,423...164,582,645
Ensembl chr 2:164,549,455...164,582,643
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:17156840
RGD:10449408
NCBI chr 5:164,844,642...164,864,360
Ensembl chr 5:164,845,925...164,860,910
G
Ncstn
nicastrin
ISS
OMIM:608232
MouseDO
NCBI chr13:90,451,046...90,467,256
Ensembl chr13:90,451,044...90,467,256
G
Npm1
nucleophosmin 1
ISO
RGD
PMID:15659732
RGD:1600902
NCBI chr10:18,080,949...18,091,062
Ensembl chr10:18,080,950...18,090,950
G
Nqo1
NAD(P)H quinone dehydrogenase 1
ISO
DNA:SNP: :609C>T (human)
RGD
PMID:16235982
RGD:10769357
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Nras
NRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Chronic myeloid leukemia
ClinVar
PMID:2674680 PMID:8120410 PMID:12460918 PMID:16291983 PMID:18390968 PMID:18948947 PMID:20130576 PMID:20179705 PMID:23134356 PMID:23414587 PMID:23515407 PMID:25157968 PMID:26619011
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Pecam1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:serum (human)
RGD
PMID:16521495
RGD:11552593
NCBI chr10:94,850,971...94,913,202
G
Per1
period circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr10:55,681,761...55,696,557
Ensembl chr10:55,687,050...55,695,994
G
Per2
period circadian regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 9:98,555,154...98,597,362
Ensembl chr 9:98,555,169...98,597,359
G
Per3
period circadian regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 5:168,088,126...168,123,482
Ensembl chr 5:168,086,998...168,123,395
G
Prame
PRAME nuclear receptor transcriptional regulator
ISO
mRNA:increased expression:mononuclear cell (human) CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168 , PMID:20838376
RGD:11535035
NCBI chr X:106,082,984...106,091,256
Ensembl chr X:106,083,203...106,085,878
G
Prtn3
proteinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr 7:12,643,712...12,646,951
Ensembl chr 7:12,643,516...12,646,960
G
RT1-Ba
RT1 class II, locus Ba
onset
ISO
DNA:polymorphism, haplotype
RGD
PMID:17893434 , PMID:17387388
RGD:11041777 , RGD:11041781
NCBI chr20:4,066,133...4,070,726
Ensembl chr20:4,066,132...4,070,721
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphism, haplotype
RGD
PMID:17893434
RGD:11041777
NCBI chr20:4,043,726...4,049,367
Ensembl chr20:4,039,413...4,049,711
G
Setbp1
SET binding protein 1
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:18398855 PMID:18414213 PMID:20436468 PMID:21371013 PMID:23222956 PMID:25741868
NCBI chr18:75,090,733...75,432,446
Ensembl chr18:75,095,632...75,207,306
G
Sh2b3
SH2B adaptor protein 3
ISS
OMIM:608232
MouseDO
NCBI chr12:40,261,990...40,265,757
Ensembl chr12:40,244,081...40,265,757
G
Sipa1
signal-induced proliferation-associated 1
ISS
OMIM:608232
MouseDO
NCBI chr 1:221,006,305...221,018,820
Ensembl chr 1:221,006,340...221,015,929
G
Smad4
SMAD family member 4
ISO
mRNA:decreased expression:blood
RGD
PMID:29951173
RGD:13782079
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
G
Srsf1
serine and arginine rich splicing factor 1
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23228155
RGD:11038774
NCBI chr10:75,334,200...75,341,197
Ensembl chr10:75,335,146...75,341,197
G
Tert
telomerase reverse transcriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168 , PMID:15068898
RGD:11038663
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
G
Tgfb1
transforming growth factor, beta 1
ISO
protein:increased expression:serum
RGD
PMID:29951173
RGD:13782079
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Vegfa
vascular endothelial growth factor A
susceptibility
ISO
DNA:SNP,haplotype: :(rs6999470),(rs833061)(human)
RGD
PMID:19141860
RGD:13432135
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr 3:95,133,221...95,180,574
Ensembl chr 3:95,133,713...95,180,564
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:SNP:cds :p.R194W(human)
RGD
PMID:26250462
RGD:11081180
NCBI chr 1:81,412,635...81,441,680
Ensembl chr 1:81,413,353...81,441,678
G
Asxl1
ASXL transcriptional regulator 1
disease_progression
ISO
DNA:mutations:exon:
RGD
PMID:20880116
RGD:11038767
NCBI chr 3:148,832,231...148,902,356
Ensembl chr 3:148,837,814...148,900,452
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
ISO
DNA:altered methylation:5'UTR:
RGD
PMID:12750705
RGD:11252180
NCBI chr 5:107,834,353...107,857,428
Ensembl chr 5:107,845,951...107,858,104
G
Csf3r
colony stimulating factor 3 receptor
disease_progression
ISO
DNA:mutations:multiples:
RGD
PMID:23774674
RGD:10450469
NCBI chr 5:144,031,353...144,051,966
Ensembl chr 5:144,031,402...144,051,600
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
severity
ISO
DNA:mutations:multiple (human)
RGD
PMID:21339759
RGD:10450882
NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
G
Kdm6a
lysine demethylase 6A
ISS
MouseDO
NCBI chr X:4,805,493...4,945,788
Ensembl chr X:4,806,277...4,945,944
G
Nras
NRAS proto-oncogene, GTPase
onset
ISO
RGD
PMID:26082490
RGD:11535058
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Tet2
tet methylcytosine dioxygenase 2
ISO
DNA:missense mutations, nonsense mutations, splice-site mutations:multiple
RGD
PMID:20693430
RGD:11038679
NCBI chr 2:238,719,389...238,802,975
Ensembl chr 2:238,720,835...238,803,024
G
Irf8
interferon regulatory factor 8
ISS
OMIM:600080
MouseDO
NCBI chr19:54,314,859...54,336,643
Ensembl chr19:54,314,865...54,336,640
G
Erbb3
erb-b2 receptor tyrosine kinase 3
susceptibility
ISO
ClinVar Annotator: match by term: LEUKEMIA, ACUTE MYELOGENOUS, M6
ClinVar OMIM
PMID:27416908
NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350
G
Runx1
RUNX family transcription factor 1
ISO
ClinVar Annotator: match by term: Platelet disorder, Aspirin-like ClinVar Annotator: match by term: Hereditary thrombocytopenia and hematologic cancer predisposition syndrome ClinVar Annotator: match by term: Familial platelet disorder with associated myeloid malignancy
OMIM ClinVar
PMID:10068652 PMID:10508512 PMID:11830488 PMID:12060124 PMID:12172547 PMID:12200707 PMID:12393679 PMID:12807882 PMID:14504086 PMID:15156185 PMID:15749889 PMID:17234761 PMID:17290219 PMID:17485549 PMID:17650443 PMID:18478040 PMID:18723428 PMID:19357396 PMID:19387465 PMID:20549580 PMID:20846103 PMID:20880108 PMID:20955399 PMID:22012064 PMID:22318203 PMID:22689681 PMID:23751892 PMID:23753029 PMID:23817177 PMID:23848403 PMID:24100448 PMID:24523240 PMID:24659740 PMID:24764152 PMID:24904105 PMID:25159113 PMID:25741868 PMID:25840971 PMID:26175287 PMID:26316320 PMID:26580448 PMID:26884589 PMID:27112265 PMID:27137476 PMID:27210295 PMID:27418648 PMID:27479822 PMID:28179279 PMID:28240786 PMID:28492532 PMID:28513614 PMID:28659335 PMID:28748566 PMID:28855357 PMID:28933735 PMID:28960434 PMID:29146883 PMID:29365323 PMID:29666006 PMID:30990344 PMID:31064749 PMID:32581362
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
G
Akap12
A-kinase anchoring protein 12
disease_progression
ISO
RGD
PMID:26891149
RGD:14348967
NCBI chr 1:40,816,130...40,906,582
Ensembl chr 1:40,816,107...40,906,581
G
Arhgap26
Rho GTPase activating protein 26
ISO
ClinVar Annotator: match by OMIM:607785
OMIM ClinVar
PMID:10908648
NCBI chr18:31,807,052...32,557,176
Ensembl chr18:31,812,109...32,207,801
G
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia
CTD ClinVar
PMID:25741868 PMID:26457647 PMID:32581362
NCBI chr 3:148,832,231...148,902,356
Ensembl chr 3:148,837,814...148,900,452
G
Cbl
Cbl proto-oncogene
ISO
DNA:mutations:cds: ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:19571318 PMID:19620960 PMID:20543203 PMID:20694012 PMID:20955399 PMID:21901340 PMID:22315502 PMID:24033266 PMID:25283271 PMID:25741868 PMID:25939664 PMID:25952305 PMID:26457647 PMID:27609087 PMID:28343148 PMID:28414188 PMID:28492532 , PMID:19571318
RGD:11038806
NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
G
Csf2
colony stimulating factor 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22315502 , PMID:9389708
RGD:10449526
NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
G
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr 6:28,205,375...28,346,052
Ensembl chr 6:28,235,695...28,340,577
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
G
Flt3
Fms related receptor tyrosine kinase 3
ISS
OMIM:607785
MouseDO
NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
G
Gata2
GATA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
G
Jak3
Janus kinase 3
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23832011 , PMID:23832011
RGD:11069125
NCBI chr16:20,107,471...20,120,678
Ensembl chr16:20,109,200...20,120,668
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia
CTD ClinVar
PMID:2278970 PMID:2547513 PMID:3122217 PMID:3627975 PMID:7773929 PMID:8439212 PMID:12460918 PMID:15696205 PMID:15842656 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17332249 PMID:17384584 PMID:17704260 PMID:17910045 PMID:18316791 PMID:18594010 PMID:18794081 PMID:19018267 PMID:19029981 PMID:19047918 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19358724 PMID:19679400 PMID:19773371 PMID:19881948 PMID:20609353 PMID:20805368 PMID:20921462 PMID:20921465 PMID:20949522 PMID:20978259 PMID:21063026 PMID:21079152 PMID:21169357 PMID:21228335 PMID:21398618 PMID:21975775 PMID:22025163 PMID:22235099 PMID:22392911 PMID:22407852 PMID:22499344 PMID:22571758 PMID:22683711 PMID:22722830 PMID:22734028 PMID:22897852 PMID:23014527 PMID:23096712 PMID:23182985 PMID:23325582 PMID:23406027 PMID:24033266 PMID:24558511 PMID:24720724 PMID:25044103 PMID:25157968 PMID:25695684 PMID:25705018 PMID:25741868 PMID:25808193 PMID:26372703 PMID:26457647 PMID:26623049 PMID:28492532 PMID:29298116 PMID:31891627 PMID:32581362
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Nf1
neurofibromin 1
ISO
ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by OMIM:607785
OMIM ClinVar CTD
PMID:1568247 PMID:8264648 PMID:9003501 PMID:9150739 PMID:9180088 PMID:9219873 PMID:9475595 PMID:9639526 PMID:10607834 PMID:10712197 PMID:10726756 PMID:10862084 PMID:10980545 PMID:11857752 PMID:12095621 PMID:12807981 PMID:14722917 PMID:15146469 PMID:15846561 PMID:16380919 PMID:16513807 PMID:16786508 PMID:16835897 PMID:16961930 PMID:17406642 PMID:18484666 PMID:18546366 PMID:19142971 PMID:21278392 PMID:22155606 PMID:22315502 PMID:22807134 PMID:23244495 PMID:23668869 PMID:23913538 PMID:24033266 PMID:24932921 PMID:25325900 PMID:25403449 PMID:25541118 PMID:25741868 PMID:26056819 PMID:26457647 PMID:26457648 PMID:26467025 PMID:26840085 PMID:27322474 PMID:27716896 PMID:27838393 PMID:28492532 PMID:29290338 PMID:29415745 PMID:29673180 PMID:31595648 PMID:32107864 PMID:32581362
NCBI chr10:66,732,460...66,928,706
Ensembl chr10:66,690,133...66,928,903
G
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia
CTD ClinVar
PMID:2278970 PMID:2407301 PMID:2674680 PMID:2989702 PMID:3122217 PMID:8120410 PMID:10598665 PMID:12460918 PMID:16273091 PMID:16291983 PMID:16434492 PMID:16518851 PMID:17332249 PMID:17384584 PMID:17517660 PMID:17699718 PMID:18375819 PMID:18390968 PMID:18794081 PMID:18948947 PMID:19047918 PMID:19075190 PMID:19657110 PMID:19775298 PMID:19966803 PMID:20130576 PMID:20179705 PMID:20619739 PMID:20736745 PMID:21079152 PMID:21263000 PMID:21305640 PMID:21729679 PMID:21829508 PMID:22144181 PMID:22407852 PMID:22499344 PMID:23414587 PMID:23431193 PMID:23515407 PMID:24284627 PMID:25157968 PMID:26457647 PMID:26619011 PMID:28098151 PMID:28492532 PMID:28594414
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
ISO
ClinVar Annotator: match by term: Juvenile myelomonocytic leukemia DNA:missense mutations:cds:multiple (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by OMIM:607785
OMIM ClinVar CTD
PMID:11704759 PMID:11992261 PMID:12058348 PMID:12161469 PMID:12161596 PMID:12325025 PMID:12634870 PMID:12717436 PMID:12739139 PMID:12960218 PMID:14634749 PMID:14644997 PMID:14676626 PMID:14961557 PMID:14974085 PMID:14982869 PMID:15001945 PMID:15121796 PMID:15240615 PMID:15248152 PMID:15273746 PMID:15385933 PMID:15389709 PMID:15520399 PMID:15539800 PMID:15604238 PMID:15644411 PMID:15710330 PMID:15712196 PMID:15723289 PMID:15761018 PMID:15834506 PMID:15842656 PMID:15928039 PMID:15929108 PMID:15956085 PMID:15985475 PMID:15987685 PMID:15996221 PMID:16053901 PMID:16078230 PMID:16115145 PMID:16124853 PMID:16263833 PMID:16338218 PMID:16358218 PMID:16377799 PMID:16399795 PMID:16461457 PMID:16498234 PMID:16518851 PMID:16533526 PMID:16638574 PMID:16679933 PMID:16804314 PMID:16990350 PMID:17020470 PMID:17143285 PMID:17177198 PMID:17339163 PMID:17361219 PMID:17497712 PMID:17515436 PMID:17546245 PMID:17661820 PMID:17910045 PMID:17935252 PMID:17972951 PMID:18253957 PMID:18331608 PMID:18372317 PMID:18373317 PMID:18378677 PMID:18470943 PMID:18562489 PMID:18678287 PMID:18758896 PMID:18759865 PMID:18849586 PMID:18854871 PMID:18925961 PMID:19008228 PMID:19020799 PMID:19047918 PMID:19054014 PMID:19077116 PMID:19133693 PMID:19174044 PMID:19179468 PMID:19251646 PMID:19352411 PMID:19509418 PMID:19725129 PMID:19737548 PMID:19768645 PMID:19773259 PMID:19825837 PMID:19835954 PMID:19864201 PMID:20112233 PMID:20308328 PMID:20493809 PMID:20535210 PMID:20651068 PMID:20718194 PMID:20883402 PMID:20954246 PMID:20979190 PMID:21339643 PMID:21340158 PMID:21365175 PMID:21365683 PMID:21407260 PMID:21555152 PMID:21567923 PMID:21590266 PMID:21706501 PMID:21747628 PMID:21901340 PMID:21910245 PMID:21930766 PMID:21934682 PMID:22190897 PMID:22315187 PMID:22315502 PMID:22371576 PMID:22411627 PMID:22420426 PMID:22465605 PMID:22555271 PMID:22585553 PMID:22681964 PMID:22711529 PMID:22781091 PMID:22822385 PMID:22923420 PMID:23312806 PMID:23317994 PMID:23321623 PMID:23334666 PMID:23334668 PMID:23457302 PMID:23513489 PMID:23584145 PMID:23673659 PMID:23726368 PMID:23756559 PMID:23813970 PMID:23825065 PMID:23832011 PMID:24033266 PMID:24037001 PMID:24401936 PMID:24451042 PMID:24628801 PMID:24718990 PMID:24754368 PMID:24767283 PMID:24775816 PMID:24803665 PMID:24820750 PMID:24935154 PMID:25097206 PMID:25326637 PMID:25331952 PMID:25383899 PMID:25395418 PMID:25500235 PMID:25544017 PMID:25585602 PMID:25595571 PMID:25612910 PMID:25731833 PMID:25741868 PMID:25741869 PMID:25884655 PMID:25912702 PMID:25917897 PMID:26084119 PMID:26242988 PMID:26337637 PMID:26457647 PMID:26467025 PMID:26619011 PMID:26673822 PMID:26785492 PMID:26817465 PMID:26822237 PMID:26918529 PMID:27069254 PMID:27153395 PMID:27238887 PMID:27276561 PMID:27484170 PMID:27521173 PMID:27626068 PMID:27659786 PMID:27783593 PMID:28051113 PMID:28098151 PMID:28363362 PMID:28483241 PMID:28492532 PMID:28628100 PMID:28650561 PMID:28681392 PMID:28957739 PMID:29276006 PMID:29493581 PMID:29555671 PMID:29907801 PMID:30311386 PMID:30868567 PMID:32581362 PMID:32860008 , PMID:12717436
RGD:11066398
NCBI chr12:40,895,515...40,955,999
Ensembl chr12:40,895,515...40,955,999
G
Rac2
Rac family small GTPase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457648
NCBI chr 7:119,769,708...119,797,111
Ensembl chr 7:119,783,849...119,797,098
G
Rras
RAS related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr 1:101,012,822...101,016,720
Ensembl chr 1:101,012,822...101,016,720
G
Rras2
RAS related 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr 1:178,940,515...179,010,257
Ensembl chr 1:178,940,516...179,010,257
G
Runx1
RUNX family transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
G
Setbp1
SET binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23832011 PMID:26457647
NCBI chr18:75,090,733...75,432,446
Ensembl chr18:75,095,632...75,207,306
G
Sh2b3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr12:40,261,990...40,265,757
Ensembl chr12:40,244,081...40,265,757
G
Zrsr2
zinc finger (CCCH type), RNA binding motif and serine/arginine rich 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26457647
NCBI chr X:32,304,707...32,327,419
Ensembl chr X:32,304,757...32,328,364
G
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Mast cell leukemia
ClinVar
PMID:7479840 PMID:7691885 PMID:8589724 PMID:9827716 PMID:9990072 PMID:11380399 PMID:11493470 PMID:15972446 PMID:16352739 PMID:16384925 PMID:16731599 PMID:16912224 PMID:17259998 PMID:18024392 PMID:18986703 PMID:19164557 PMID:19262599 PMID:19865100 PMID:21689725 PMID:22504184 PMID:23582185 PMID:23714533 PMID:24045550 PMID:25157968 PMID:25741868 PMID:26158763 PMID:26822237 PMID:27777718 PMID:28492532
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
G
Samd9
sterile alpha motif domain containing 9
ISO
ClinVar Annotator: match by term: MONOSOMY 7 MYELODYSPLASIA AND LEUKEMIA SYNDROME 2
OMIM ClinVar
PMID:2569483 PMID:28487541 PMID:30046003
NCBI chr 4:28,304,967...28,324,637
Ensembl chr 4:28,305,002...28,310,178
G
Apc
APC regulator of WNT signaling pathway
ISO
ClinVar Annotator: match by term: Myeloid Leukemia Associated with Down Syndrome
ClinVar
PMID:24033266 PMID:24448499 PMID:24618431 PMID:25186627 PMID:25741868 PMID:25980754 PMID:26467025 PMID:26845104 PMID:27930734 PMID:28492532 PMID:31422818
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
G
Ctcf
CCCTC-binding factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr19:37,600,151...37,649,674
Ensembl chr19:37,600,148...37,649,673
G
Dcaf7
DDB1 and CUL4 associated factor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr10:94,231,585...94,254,046
Ensembl chr10:94,231,585...94,254,046
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr 4:77,284,404...77,347,011
Ensembl chr 4:77,284,404...77,347,011
G
Gata1
GATA binding protein 1
ISO
ClinVar Annotator: match by term: Leukemia, megakaryoblastic, of Down syndrome
ClinVar
PMID:12172547 , PMID:14636651
RGD:10450612
NCBI chr X:15,273,937...15,281,759
Ensembl chr X:15,378,789...15,382,066
G
Kansl1
KAT8 regulatory NSL complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr10:92,388,045...92,517,449
Ensembl chr10:92,389,530...92,476,109
G
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr 2:205,553,119...205,563,716
Ensembl chr 2:205,553,163...205,560,791
G
Rad21
RAD21 cohesin complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr 7:91,511,755...91,538,673
Ensembl chr 7:91,511,756...91,538,673
G
Stag2
stromal antigen 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr X:128,493,603...128,624,418
Ensembl chr X:128,493,614...128,624,418
G
Tp53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24056718
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
G
Bmi1
BMI1 proto-oncogene, polycomb ring finger
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24571310
NCBI chr17:85,360,439...85,370,283
Ensembl chr17:85,364,483...85,368,208
G
Mir150
microRNA 150
ISO
miRNA:decreased expression:leukocytes
RGD
PMID:21501493
RGD:13782140
NCBI chr 1:101,115,974...101,116,058
Ensembl chr 1:101,115,974...101,116,058
G
Abl1
ABL proto-oncogene 1, non-receptor tyrosine kinase
disease_progression
ISO
DNA:hypermethylation:promoter
RGD
PMID:19344397 , PMID:11559572
RGD:11038809 , RGD:11038811
NCBI chr 3:10,041,820...10,145,076
Ensembl chr 3:10,041,826...10,144,388
G
Bcr
BCR activator of RhoGEF and GTPase
disease_progression
ISO
RGD
PMID:19344397
RGD:11038809
NCBI chr20:14,421,250...14,546,406
Ensembl chr20:14,421,141...14,545,772
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
treatment
ISO
DNA:polymorphism:intron :6986A>G(human)
RGD
PMID:23394475
RGD:11353797
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
ISO
DNA:SNP: :rs11615 (human)
RGD
PMID:22821389
RGD:11252165
NCBI chr 1:80,256,973...80,268,198
Ensembl chr 1:80,256,973...80,268,198
G
Gfi1
growth factor independent 1 transcriptional repressor
disease_progression
ISO
mRNA,protein:increased expression:mononuclea cell, CD34+ cell
RGD
PMID:19887785 , PMID:23411466
RGD:11040457 , RGD:11040461
NCBI chr14:3,058,035...3,073,332
Ensembl chr14:3,058,993...3,068,371
G
Gfi1b
growth factor independent 1B transcriptional repressor
ISO
mRNA:increased expression:blood:
RGD
PMID:19360458
RGD:11040460
NCBI chr 3:7,190,721...7,203,444
Ensembl chr 3:7,190,722...7,203,420
G
Ccr2
C-C motif chemokine receptor 2
ISO
associated with Leukemia, Myeloid, Acute;protein:increased expression:blood, leukocyte
RGD
PMID:20582977
RGD:8661751
G
Kras
KRAS proto-oncogene, GTPase
ISO
associated with Leukemia, Myeloid, Acute;DNA:missense mutation:exon:p.G12C (human)
RGD
PMID:23564351
RGD:11060142
NCBI chr 4:179,482,562...179,515,483
Ensembl chr 4:179,486,105...179,515,558
G
Pdgfra
platelet derived growth factor receptor alpha
treatment
ISO
RGD
PMID:22348015
RGD:11075098
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
G
Pdgfrb
platelet derived growth factor receptor beta
ISO
OMIM
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
G
Cbl
Cbl proto-oncogene
ISO
ClinVar Annotator: match by term: Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ClinVar Annotator: match by term: Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia ClinVar Annotator: match by OMIM:613563
OMIM ClinVar
PMID:17446348 PMID:18698078 PMID:19387008 PMID:19571318 PMID:19620960 PMID:19901108 PMID:20543203 PMID:20595524 PMID:20619386 PMID:20694012 PMID:20951944 PMID:21828135 PMID:22246246 PMID:22733026 PMID:23690417 PMID:23696637 PMID:23823657 PMID:24033266 PMID:24458550 PMID:24728327 PMID:24896146 PMID:25178484 PMID:25224413 PMID:25283271 PMID:25358541 PMID:25731833 PMID:25741868 PMID:25939664 PMID:25952305 PMID:27069254 PMID:28414188 PMID:28492532 PMID:28589114 PMID:29296819
NCBI chr 8:48,481,256...48,564,775
Ensembl chr 8:48,489,036...48,564,722
G
Mcam
melanoma cell adhesion molecule
ISO
ClinVar Annotator: match by term: Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia
ClinVar
NCBI chr 8:48,472,824...48,481,005
Ensembl chr 8:48,472,824...48,481,001
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
ISO
ClinVar Annotator: match by term: Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia
ClinVar
PMID:11992261 PMID:12058348 PMID:12161596 PMID:14634749 PMID:15121796 PMID:15389709 PMID:15520399 PMID:16053901 PMID:16358218 PMID:16377799 PMID:16638574 PMID:16679933 PMID:17020470 PMID:18372317 PMID:18849586 PMID:19725129 PMID:19768645 PMID:20308328 PMID:21339643 PMID:21747628 PMID:22681964 PMID:22822385 PMID:23673659 PMID:24033266 PMID:24401936 PMID:24775816 PMID:24820750 PMID:24935154 PMID:25731833 PMID:25741868 PMID:25917897 PMID:26337637 PMID:26918529 PMID:28483241 PMID:28492532 PMID:29276006 PMID:30311386
NCBI chr12:40,895,515...40,955,999
Ensembl chr12:40,895,515...40,955,999
G
Bcl2l10
BCL2 like 10
susceptibility
ISO
DNA:SNP:cds:p.Leu21Arg rs2231292)(human)
RGD
PMID:24047476
RGD:11058140
NCBI chr 8:82,288,705...82,294,750
Ensembl chr 8:82,288,705...82,294,744
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
associated with neoplasms;
RGD
PMID:17367411
RGD:10450873
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
G
Klf1
Kruppel like factor 1
ISO
RGD
PMID:12417757
RGD:10769345
NCBI chr19:26,016,289...26,019,557
Ensembl chr19:26,016,382...26,019,553
G
Runx1
RUNX family transcription factor 1
ISO
DNA:translocations:intron:multiple
RGD
PMID:9763573
RGD:11251709
NCBI chr11:32,765,147...33,003,061
Ensembl chr11:32,769,165...33,003,021
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all